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ABSTRACT 
Controlling influenza A virus (IAV) infections remains a challenge largely due to the 
high replication and mutation rates of the virus. IAV is a negative-sense RNA virus with two 
main surface proteins — hemagglutinin (HA) and neuraminidase (NA). HA recognizes and binds 
sialic acid on host cell receptors to initiate virus entry. NA also recognizes sialic acid on host cell 
receptors but functions by cleaving sialic acid interactions to release progeny virus. Because both 
HA and NA interact with sialic acid on the host cell surface with opposing effects, their balance 
is essential for optimal viral infectivity. However, the evolutionary constraints that maintain HA 
and NA function, while conserving a functional balance, are not fully understood.  
 I adapted the comprehensive and systematic mutational scanning technology, termed 
EMPIRIC (Exceedingly Meticulous and Parallel Investigation of Randomized Individual 
Codons), to investigate the local fitness landscape of regions of HA under standard conditions 
and under drug pressure. We observed that synonymous substitutions had a higher mean absolute 
fitness effect in the signal than a neighboring HA region used as a control. Folding ∆G 
calculations revealed a hairpin loop that appeared to be differentially enriched between human 
and swine IAV variants in sequences of circulating strains. However, the molecular mechanism 
resulting in the observed host species-specific constraints remains undefined. 
Studying the fitness landscape of the receptor binding site of HA revealed the high 
sensitivity of this region to mutation. However, modulating the levels of NA activity by mutation 
and by using the NA inhibitor oseltamivir enabled the identification of HA mutations with 
adaptive potential under selection pressure by oseltamivir. These results highlight the importance 
of the HA-NA functional balance virus replication and in the development of resistance to 
oseltamivir inhibitors. These studies provide improved understanding of IAV biology, and can 
inform the development of improved antiviral agents with reduced likelihood for resistance. 
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Chapter I:  Introduction 
Influenza and global public health 
Influenza viruses are important pathogens that cause upper respiratory tract infections in 
humans and are a global public health concern. Inhaling virus-containing droplets is the most 
common mode of transmission of influenza viruses [1]. Symptoms of influenza infections 
typically last 3-5 days and include sore throat, runny nose, coughing, muscle ache, and fever. 
Complications such as bronchitis, sinusitis, and pneumonia may occur in individuals such as the 
elderly, pregnant women, and in children under 5 years of age, leading to increased morbidity 
and mortality [2, 3]. The increasing cost of treatment combined with missed work days due to 
illness make influenza infections a great burden to global economic development [4].  
The World Health Organization estimates about 3-4 million cases of severe influenza 
infections annually resulting in up to 500,000 deaths worldwide [5]. In temperate climates, 
seasonal influenza outbreaks often happen in the colder months of October to February, while 
influenza outbreaks may happen year-round in the tropics. In addition to seasonal influenza 
outbreaks, influenza caused four pandemics in the 20th and 21st centuries [6, 7]. The 1918 
Spanish flu alone caused 50-100 million deaths worldwide and remains the deadliest pandemic 
in history [6, 8]. The Asian flu of 1957 and the Hong Kong flu of 1968 caused up to six million 
deaths combined [7]. Even with this scale of mortality, effective control of influenza infections is 
yet to be achieved. As such, improved pandemic preparedness will help reduce morbidity and 
minimize mortality in preparation for the next pandemic.  
 
The causative agent 
 
Influenza infections are caused by viruses that belong to the Orthomyxoviridae family, a 
family composed of three important genera [9]. Influenza B and C are known to only replicate in 
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human hosts whereas influenza A virus (IAV) replicates in human and non-human hosts such as 
chicken, ducks, swine, horses and bats [10-13]. IAV is the most virulent genera and causes the 
most severe infections in humans. Influenza B causes significantly fewer infections each year. 
However, a recent study by the Centers for Disease Control and Prevention reports that influenza 
B infections can be just as severe as infections caused by IAV [14], unlike previous theories.  
IAV is an enveloped negative sense RNA virus that is roughly spherical in shape with a 
diameter of 100-120 nanometers [9]. The IAV genome is composed of eight single-stranded 
RNA segments, a genome organization with notable evolutionary plasticity by genetic 
reassortment. IAV genome segments are numbered by length from the longest to the shortest 
[15]. Each RNA segment is in complex with three polymerase subunits ((polymerase basic 2 
(PB2), polymerase basic 1 (PB1) and polymerase acidic (PA)), and nucleoprotein (NP) encoded 
by RNA segments 1, 2, 3, and 5, respectively [16, 17]. Segments 4 and 6 encode the 
hemagglutinin (HA) and neuraminidase (NA) proteins that form the majority of surface 
glycoproteins of IAV. HA recognizes and binds host receptors to initiate infection [18], while 
NA cleaves host-virus interactions to allow the release of progeny virus [19]. Matrix proteins M1 
and M2 are encoded by alternative reading frames on segment 7 [20]. M1 is the most abundant 
IAV protein that encapsulates viral ribonucleoprotein (vRNP) complexes [21]. M2 forms ion 
channels in the viral envelope allowing proton exchange between the virus and the cellular 
environment at low pH [22]. Segment 8 encodes the nonstructural proteins NS1 and NS2 in 
alternate open reading frames [23]. NS1 enhances the translation of viral mRNA and also 
inhibits host antiviral responses to allow viral propagation in the host [24]. NS2 mediates nuclear 
export of vRNP complexes after synthesis [25].  
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IAV is divided into subtypes based on the antigenic properties of HA and NA on the 
virus surface. Thus far 18 HA and 11 NA subtypes have been identified [13, 26]. Circulating 
viruses have different combinations of HA and NA subtypes - such as H1N1, H3N2 and H5N1. 
Most IAV strains are isolated from aquatic wild birds which serve as natural reservoirs for the 
virus [27]. Some variants such as H1N1, H3N2 and H7N2 are known to exclusively infect and 
circulate in humans, whereas H5N1 and H7N7 infect birds and are highly pathogenic. Pigs can 
be infected by both human and avian variants and therefore serve as mixing vessels for IAV. 
However, the role of viral and host factors in cross-species transmission and infectivity remain 
unclear. Understanding how IAV evolution influences virus function and infectivity in different 
host environments will help control the spread of influenza infections and inform improved 
prophylactic and therapeutic strategies.  
New viral subtypes arise because the IAV genome is rapidly evolving. The process of 
genetic drift results from the error-prone RNA polymerase of IAV that leads to the accumulation 
of up to 10-4 nucleotide substitutions per site per year [28]. Additionally, the reassortment of 
viral RNA in hosts co-infected with different viral subtypes also contributes to genome changes 
by genetic shift. Transmission of antigenically novel zoonotic IAV strains to humans has been 
associated with all four influenza pandemics of the 20th and 21st centuries [29]. For instance, 
human IAV strains that had acquired RNA segments encoding avian-like variants were 
responsible for the 1957 and 1968 pandemics [30, 31]. Recently the H5 and H7 strains 
previously crossed the avian-human interspecies barrier and were responsible for the deadly 
avian flu outbreaks in Hong Kong [32]. Understanding the complex mechanism of cross-species 
transmission of IAV will help control cross-species transmission and provide better preparedness 
for pandemic IAV. 
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HA and NA are the main surface proteins in IAV  
HA is a 75 kDa type I transmembrane protein that binds to host receptors and mediates 
virus entry into the host cell [18] (Fig. 1.1a). The 18 known subtypes of HA are classified into 2 
groups. Group 1 contains H1, H2, H5, H6, H8, H9, H11, H12, H13, H16, H17, and H18, while 
group 2 is composed of H3, H4, H7, H10, H14, and H15 [13, 33]. During virus replication in the 
host cell, HA is synthesized as the precursor protein HA0 and undergoes co-translational 
trimerization in the ER-golgi complex [34]. Translocation to the ER is mediated by the signal 
sequence that is formed by the first 14 to 17 amino acids at the N-terminal [35]. The signal 
sequence is cleaved and does not form part of the surface expressed protein. Proteolytic cleavage 
of HA0 by host serine proteases results in the HA1 and HA2 subunits that remain linked by 
disulfide bonds. After cleavage, HA1 forms the globular head composed of the first 320 amino 
acids while HA2 is composed of 222 amino acids and forms the tail [36]. Previous studies have 
shown a correlation between HA0 cleavability by host proteases and virus pathogenicity [36]. 
Maintaining protease activation to form HA1 and HA2 while rapidly accumulating mutations 
highlights one the many functional constraints shaping IAV evolution.  
 The HA1 region of HA is distal to the virus membrane and carries both the antigenic 
sites and the receptor binding site. The amino acid sequence of the antigenic sites is unique for 
each HA subtype but evolves rapidly thus leading to evasion from neutralization by host 
antibodies [37]. On the other hand, the sequence of the receptor binding site is generally 
conserved [38]. The binding site is composed of the 190-a helix loop, the 130-loop, and the 220-
loop arranged to form a receptor binding pocket [18, 38]. The interaction between the receptor 
binding site and the terminal sialic acid on host receptors determines host specificity. HA of 
human IAV is recognized by α-2,6-linked sialic acid terminating glycans on receptors while HA 
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of avian IAV is recognized by α-2,3-linked sialic acid [39]. The reason pigs can be infected by 
both human and avian strains of IAV and serve as mixing vessels for the virus is because 
epithelial cells in the porcine trachea contain both α-2,3- and α-2,6-linked receptors [40].  
Mutations in the receptor binding site that lead to a switch in host specificity have been 
identified [41]. Specifically, the laboratory-selected L226Q mutant exhibits reduced binding 
affinity to α-2,6-linked receptors and improved binding to α-2,3 receptors. Switches in host 
specificity remain of great clinical importance due to the rich abundance of α-2,3-linked sialic 
acid in the mucins from human lungs [39]. The mucus lining is thought to minimize virus 
infections yet these receptors in the human lungs have been the source of high mortality 
pneumonia in influenza complications. 
The HA2 region of HA mediates fusion between the viral and endosomal membranes that 
lead to the introduction of vRNP into the host cell. Membrane fusion is initiated by the fusion 
peptide region of HA2 [42]. This region is comprised of the first 23 amino acids of HA2 and is 
highly hydrophobic. In surface-expressed HA, the fusion peptide folds into a spring-loaded 
structure buried in the core of the trimer, giving HA a metastable conformation [43]. However, 
during membrane fusion, HA undergoes irreversible conformational change wherein the fusion 
peptide is released from the buried state and propelled to anchor onto the host membrane. Further 
structural rearrangement in HA2 ultimately leads to the fusion of viral and host membranes. As 
such, HA2 has highly conserved structural and functional requirements compared to HA1. 
Analysis of diverse HA sequences has revealed 30-70% sequence identity between different HA 
subtypes with higher conservation in HA2 than HA1 [44].   
NA is a type II transmembrane protein (470 amino acids, 240 kDa). During infection, NA 
functions as a sialidase and cleaves sialic acid interactions between the virus and the host cell to 
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prevent virus aggregation and allow the release progeny virus [45]. NA sequences are classified 
into two phylogenetic groups. Group 1 consists of N1, N4, N5 and N8 subtypes, while group 2 
consists of N2, N3, N6, N7 and N9; the newly identified N10 and N11 appear to be distantly 
related to both group 1 and group 2 [13]. Comparing amino acid sequences reveals 37.3–66.8% 
sequence identity between NA subtypes [46].  
Structurally, NA is divided into a head region that is formed by six identical antiparallel 
β-sheets and a fibrous stalk region [19] (Fig. 1.1b). Surface NA functions as a homotetramer. 
The enzymatic active site of NA is located on the head region and is highly conserved. Eight 
catalytically important residues, R118, D151, R152, R224, E276, R292, R371, and Y406 (in N2 
numbering), are conserved in all NA subtypes [47]. Due to the functional importance and high 
sequence conservation, the NA active site serves as an effective target for anti-IAV agents. NA 
inhibitors such as oseltamivir and zanamivir are used widely to treat influenza infections. 
However, the emergence of oseltamivir resistance mutations like H275Y and N295S undermine 
the dependability of NA inhibitors for long-term use against influenza infections [48]. 
Nonetheless, there is increased interest in developing universal influenza vaccines that target 
these functionally conserved residues on the active site of NA [46, 49]. While such antibodies 
have demonstrated neutralization potential in mouse models, their application in human subjects 
and the potential for neutralization evasion remains underexplored.  
 
The IAV infection cycle 
During infection, HA binds terminal sialic acid on host cell receptors to initiate viral entry (Fig. 
1.1c). At this stage of infection NA enzyme activity must be appropriately balanced to allow  
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Figure 1.1. HA and NA form the major surface proteins of IAV. A) HA functions as a homotrimer. Each 
monomer is composed of a head region (orange) and a stem region (cyan) (PDB 1RUZ). B) NA functions 
as a tetramer. Each monomer is composed of a mushroom-shaped head region and a fibrous stalk (PDB 
3BEQ). C) Illustration of the IAV infection cycle. 
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productive host-pathogen interaction culminating in receptor-mediated endocytosis [50]. A drop 
in the endosomal pH to between 5 – 6 triggers an irreversible conformational change in HA 
leading to membrane fusion and the release of vRNP into the host cell [51]. Studies have shown 
that net charge in the cavity surrounding the fusion peptide determines the pH at which 
membrane fusion occurs [42]. Mutating charged residues near the fusion peptide leads to the 
elevation of the fusogenic pH. Targeting the membrane fusion step as a therapeutic target proved 
futile as viruses quickly developed resistance against the proton pump inhibitors amantadine and 
rimantadine [52]. 
Upon entering the cytoplasm of the host cell, vRNP are trafficked to the nucleus for 
transcription and replication. Transcription of viral RNA (vRNA) is initiated by cis-acting viral 
RNA polymerase bound to the promoter region on the vRNA template [53]. The viral 
transcription mechanism relies on 5’-capped host mRNA primers acquired by cap-snatching 
[54]. IAV also depends on host splicing machinery to splice mRNA encoding matrix and non-
structural proteins. Viral factors are proposed to regulate splicing of viral mRNA, although the 
mechanism remains unknown [55, 56]. Nuclear export factor encoded by NS2 mediates the 
export of polyadenylated mRNA to the cytoplasm for translation into viral proteins [25]. IAV 
uses host translation and secretory machinery to synthesize, fold, and modify viral proteins [34].  
vRNA replication in the nucleus occurs in two steps. The first step involves copying the 
vRNA into complementary RNA (cRNA) and the second step entails using cRNA as a template 
to produce more vRNA [57]. Previous studies have shown that newly synthesized vRNA is 
selectively exported from the nucleus, yet the molecular basis of this selectivity remains unclear 
[58]. The transcription and replication machinery of IAV serve as potential targets for antiviral 
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agents. As such, understanding the molecular mechanism and the regulation of transcription and 
replication will help to facilitate the development of improved therapeutic agents against IAV.  
In preparation for the release of newly synthesized virions, segment-specific packaging 
signals in the vRNA segments promote the packaging of a complete set of unique RNA segments 
into progeny virus [59]. Budding of the host cell membrane and NA cleavage of pre-existing 
interactions between HA and sialic acid promotes the release of newly synthesized viruses from 
infected cells. However, the molecular mechanism by which IAV hijacks cellular processes and 
promotes viral replication and release while evading complete neutralization by the host is not 
fully understood. 
 
Functional balance in receptor binding by HA and receptor destroying by NA 
HA and NA both interact with sialic acid on the surface carbohydrates of host cells 
resulting in virus entry and exit, respectively. Because HA and NA share a substrate, balance 
between the receptor binding avidity of HA and the enzymatic activity of NA is important for 
productive infection. However, the influence of this functional balance on IAV pathogenicity and 
cross-species transmission remains poorly understood. Studies have shown that different HA 
subtypes bind receptors with different affinity and that different NA subtypes have different 
levels of enzyme activity [60]. It is generally accepted that circulating viruses have matched 
receptor binding and receptor-destroying activity. The fact that there are 18 HA and 11 NA 
subtypes but only a limited number of HA-NA combinations have been isolated in circulating 
variants provides evidence that some combinations are not well-suited for virus infectivity [61]. 
Zhang et al. have shown that experimental reassortment studies of the IAV genome result in 
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strains with varying titers and infectivity [62], suggesting the likely unmatched levels of HA and 
NA function. 
Studies by the Kawaoka group have shown that NA stalk length is important for optimal 
NA function. Shortening the NA stalk by introducing large deletions led to attenuated enzyme 
function [63]. However, this group showed that manipulating HA receptor binding strength by 
introducing mutations near the receptor binding site allowed the rescue of virus function. On the 
flip side, other studies have shown that mutations that alter HA receptor binding strength can 
also be rescued by mutations in NA [64-66]. These observations indicate that the HA-NA 
functional balance is often re-established following offsetting events such as mutations, thus 
highlighting its importance in virus function. 
The significance of this functional balance has been well established. However, little is 
known on the role of this functional balance in interspecies transmissibility and pathogenicity of 
IAV. For example, it is now known that the 2009 pandemic originated from the reassortment of 
two IAV strains of swine origin neither of which was suited for human-human transmission [29, 
65, 67]. Analysis of the HA and NA functional levels revealed that the 2009 pandemic strain had 
elevated levels of NA function to balance HA function. This functional balance was absent in the 
progenitor swine variants [65]. However, the molecular changes that must happen in IAV in the 
swine that enable the crossing of the human-swine interspecies barrier followed by sustained 
transmission in human hosts are not fully understood. Nevertheless, productive virus entry into 
host cells is only successful if the HA-NA functional balance at the onset of infection allows 
productive binding of HA to host receptors without interference by NA. The balance in receptor 
binding and receptor cleavage at the onset of infection remains understudied.  
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Cross-reactive broadly neutralizing antibodies against IAV 
Broadly neutralizing antibodies (bNAb) neutralize IAV by targeting highly conserved 
functional regions of HA and either inhibit HA binding to host cell receptors, or inhibit the 
essential pH-induced conformational changes in HA required for membrane fusion. The first 
cross-reactive bNAb, C179, was isolated in 1993 from mice vaccinated with H2N2 viruses [68]. 
Since then numerous bNAb have been described. Antibodies targeting the receptor binding site 
such as (C05, S139 and F045-092) have been shown to neutralize several strains within each 
IAV subtype [69]. The HA stem has more stringent functional requirements than the head region. 
As such, stem-binding antibodies that lock the HA stem in the pre-fusion state to inhibit the pH-
induced conformational changes in HA2 have shown heterosubtypic neutralization potential. 
CR6261, F10 and C179 are bNAbs that share an epitope that covers a conserved Trp-21 
hydrophobic pocket on the HA stem and neutralize group 1 viruses. bNAbs that neutralize group 
2 viruses, such as CR8043 and CR8020, bind a separate but overlapping epitope near the base of 
the HA stem. Heterosubtypic antibodies that neutralize both group 1 and group 2 viruses, such as 
39.29, FI6 and CR9114, have also been identified. These antibodies bind an epitope that overlaps 
that of group 1-neutralizing antibodies and extends to the base of the HA stem while excluding 
subtype-specific glycans [69]. 
Due to the potential for use of antibody-based therapies as an additional strategy to 
control influenza infections, the field of bNAb discovery has grown exponentially in the last 
decade. Several heterosubtypic anti-HA antibodies have reached various stages of clinical 
development [69, 70]. These antibodies have shown significant reductions in virus titer in 
healthy adult volunteers infected with attenuated virus [71, 72]. The bNAb 39.29 advanced to 
use in naturally infected uncomplicated patients. However, laboratory evolution studies with 
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both 39.29 and F10 have identified neutralization resistant variants ([73], and in submitted work 
by Prachanronarong et al.). The molecular mechanism and evolutionary significance of 
neutralization evasion against stem-binding antibodies is not fully understood. Studying 
resistance to broad spectrum antibodies will help facilitate the design of antibody-based 
therapies, and structure-based vaccines that can elicit production of broad spectrum antibodies 
and minimize neutralization escape.  
 
Controlling seasonal IAV outbreaks 
The most effective way to control influenza infections to date is by annual vaccination. 
There are two vaccine formulations currently in use – the trivalent influenza vaccine (TIV) and 
the live attenuated influenza vaccine (LAIV) [74]. TIV consist of two influenza A strains and 
one influenza B strain inactivated viruses. The vaccine is reformulated annually based on virus 
strains projected to dominate the upcoming flu season, and is predominantly administered as an 
intramuscular injection. LAIV also contain 3 virus strains and is administered intranasally. 
Unlike TIV, LAIV consist of functionally attenuated TIV and are currently not recommended for 
use due to ineffectiveness. Due to antigenic drift, the influenza vaccine has to be reformulated 
annually. Mismatch in the vaccine strains of IAV and the circulating strains increases the 
difficulty of controlling influenza infections. A universal vaccine that can elicit the production of 
broadly neutralizing antibodies that protect against all influenza variants will provide a solution 
to the vaccine mismatch problem. As of yet, this holy grail of influenza vaccines still remains to 
be developed.  
The most common method used to produce the influenza vaccine in the United States is 
the egg-based method [75]. This process begins when the WHO surveillance and response team 
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provides the candidate influenza strains predicted to dominate in the upcoming flu season. This 
often happens in February in the northern hemisphere and in September in the southern 
hemisphere [76]. The candidate viruses are injected into eggs and cultured to allow for virus 
replication. Virus-containing fluid is then harvested and purified. Recovered virus is inactivated 
and goes through several rounds of testing before packaging for use in administered vaccines. 
Predicting the influenza variants projected to dominate in the upcoming flu season follows the 
analysis of circulating clinical isolates. However, factors such as mismatch in the predicted viral 
strain and poor growth of certain strains in chicken eggs continue to undermine the effectiveness 
of the influenza vaccine. 
The identification of cold-adapted IAV that exhibited dominant negative properties and 
suppressed the growth of wild type viruses in cell culture proved to be a promising strategy to 
control the virus [77]. These viruses carried a mutation in the matrix protein and showed 
evidence of reduced infection when studied as a live-virus in ferrets [78]. However, this new 
approach to control IAV infections was not developed for use in a clinical setting. 
Antiviral drugs are currently used to reduce the viral load in the host helping to alleviate 
symptoms and shorten the duration of illness. Most individuals respond well to antiviral drugs. 
However, life-threatening complications may occur in immunocompromised individuals. M2 ion 
channel inhibitors, amantadine and rimantadine are some of the earliest drugs that were approved 
to treat influenza. Widespread resistance to M2 inhibitors has rendered these drugs unfit for use 
in treating influenza [52]. Oseltamivir, zanamivir and peramivir inhibit NA function therefore 
blocking viral shedding [79]. Even the relatively successful therapeutic agents such as 
oseltamivir have limitations. For instance, the initiation of treatment relative to the onset of 
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infection affects the outcome. Additionally, the emergence of drug resistant viruses following 
treatment with these drugs remains a challenge.  
 
Approaches to investigate influenza evolution 
Phylogenetic methods have been widely used to study IAV evolution [80, 81]. One 
limitation of using this method is the sparsity of sequencing data for strains that circulated in the 
early 20th century. Inadequate sampling of sequences may result in punctuated and inconclusive 
analyses of some phylogenies. Additionally, phylogenetic inferences may undermine important 
evolutionary constraints underlying the clustering of IAV variants. For instance, about 53% of 
diversity observed in HA1 of H3 variants results from the 18 codons near the antigenic sites that 
appear to be under positive selection, while the rest of the 311 residues are more conserved [82]. 
Additionally, in analyzing IAV evolution, the inability to distinguish genomic reassortment 
between related strains from genetic drift events may lead to inaccurate phylogenetic clustering 
[83]. Ultimately, phylogenetic inferences and the corresponding predictive power provide useful 
information but need to be backed by experimental data.  
Efforts to reconstitute influenza virus for study in the laboratory began in the 1980s and 
ultimately led to the isolation and characterization of replication-competent vRNP [84, 85]. 
Parvin and colleagues were able to transcribe full-length vRNA by combining purified 
polymerase with vRNP. These advances led to research using recombinant influenza virus 
recovered from cloned cDNA and helper viruses [86]. The over-abundance of helper virus in the 
pool of recovered virus greatly limited the applications of this approach. Technological 
advances, by the Newmann and Webster groups, in modifying the polymerase I systems 
combined with cloning all 8 segments of the A/WSN/1933 H1N1 strain of IAV greatly improved 
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the reverse genetics approaches used to study IAV [15, 86]. The success of this technology has 
provided an excellent platform to study IAV biology. 
The 8-plasmid system revolutionized the study of IAV evolution. Passaging viruses in 
cell culture and using Sanger sequencing to analyze mutations that emerge allowed the study of 
genetic drift and the analysis of reassortment between IAV subtypes [15]. Incorporating DNA 
manipulation technologies allowed the introduction of point mutations and sequence deletions to 
the IAV genome thus providing a better understanding of the structure-function relationships in 
IAV proteins, viral pathogenicity and evolution [87]. However, these approaches were extremely 
low-throughput allowing the analysis of a handful of mutations at a time. Additionally, these 
methods failed to sample all possible mutations similar to the mutational space available to 
circulating viruses.  
 
Massively parallel mutational scanning approaches used to protein evolution 
Alanine scans were the earliest methods used for mutational scanning [88]. Mutating 
each amino acid to alanine allowed the study of the structural and functional properties of each 
amino acid in a protein. While this approach is informative, alanine scans fail to capture the kind 
of mutations that happen in nature wherein random nucleotide mutations result in either 
synonymous or non-synonymous amino acid changes. The ability to randomize amino acids to 
all other possible amino acids would provide a more comprehensive picture of the effects of 
mutations on protein function. 
Fitness landscapes represent the fitness effects of all possible combinations of mutations 
in a protein [89]. However, even for the smallest protein, the number of variants required to 
generate a complete fitness landscape remain experimentally intractable. Studying local fitness 
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landscapes can provide information on the evolutionary process of a protein. Recently developed 
methods that combine high-throughput site-directed mutagenesis and massively parallel 
sequencing, present a comprehensive study of sequence-structure-function relationships in a 
protein. These high-throughput mutational scans, such as the exceedingly methodical and 
parallel investigation of randomized individual codons (EMPIRIC) [90] and the deep mutational 
scanning (DMS) approach [91] use methods such as error-prone PCR, cassette-based 
mutagenesis and chemical synthesis to introduce all possible mutations to parts or the whole 
protein. Expression of plasmid libraries in a genetically tractable system such as phage display, 
bacteria, yeast, virus or mammalian cells followed by bulk competition allows for the enrichment 
of functional variants and the depletion of deleterious ones. Using next-generation deep 
sequencing and barcoding technology allows the analysis of the change in mutant frequency for 
up to hundreds of thousands of mutants [90-93].  
High-throughput mutational scanning approaches have been used in directed evolution 
studies to study the effects of different selective pressures on the fitness landscape of proteins. 
Additionally, mutational data in combination with structural, biochemical and thermodynamic 
analyses has provided information on epistasis, protein evolvability and the development of drug 
resistance. However, analysis of additional viral proteins will be important in discerning whether 
or not the fitness constraints observed thus far apply to other proteins. Combining results of 
fitness scans and mathematical modeling provides improved understanding of protein evolution.  
 
Limitations of massively parallel deep sequencing approaches 
Patterns of mutational tolerance observed in experimental evolution studies occasionally 
diverge from sequence conservation patterns seen in nature [94]. Some mutations appear to have 
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minimal experimental fitness effects and yet appear to be absent in natural sequences. This may 
be due to factors such as the role of epistasis in protein evolution, differences in the 
environmental conditions tested [94, 95], differences in the time scale between natural evolution 
and experimental evolution studies, and the effective population size [96]. Despite this 
discontinuity, high-throughput mutagenesis studies enhance our understanding of protein 
function. With the rapid increase in the number of large-scale mutagenesis datasets, the future 
will see a rise in experimentally informed models that can improve protein engineering and 
enable us to predict functional consequences of mutations with confidence and therefore predict 
protein evolution. Predicting the evolution of viral proteins will allow the prediction of drug 
resistance mutations before they arise and become a public health concern.  
Advances in high-throughput sequencing technologies have made high-throughput 
sequence-based methods a cost-effective approach to study protein evolution. However, there are 
some limitations that need to be addressed in order to ensure increased accuracy in measuring 
mutational fitness effects. First, quick and affordable methods that warrant unbiased 
representation of mutants in starting plasmid libraries are yet to be achieved. Second, some 
random mutagenesis approaches generate libraries carrying a mixture of single and multiple 
mutations. These methods allow the measurement of fitness effects as averages of effects in 
closely related but not identical genetic backgrounds, thus complicating the interpretation of 
sequence-function relationships. Another challenge is in the bottleneck effects encountered 
during expression of the plasmid libraries or in the bulk competition assays. Such bottlenecks 
can be avoided by improved population management to ensure sufficient mutational diversity 
throughout the experiment thus avoiding stochastic sampling of mutations [97]. Low sequencing 
coverage and high read errors leading to high sampling noise in sequencing results pose another 
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challenge [98, 99]. Sequencing samples to sufficient read depth, using paired-end sequencing 
when possible and the use of unique barcodes have greatly improved the quality of sequencing 
results. Applying this technology to re-emerging viral diseases, such as influenza, that pose great 
threat to global public health will help inform the control of seasonal flu outbreaks and minimize 
pandemics.  
 
Using high-throughput fitness scans to study IAV 
High-throughput mutational scanning approaches have been used widely to study IAV 
function and evolution. Previous studies have used this approach to investigate effect of 
mutations on virus function [100-102] and in response to host innate immunity responses [103, 
104]. Additionally, mutational scanning approaches have also been used to study the role of 
environmental factors, such as antiviral agents and neutralizing antibodies, on IAV evolution 
[100]. However, bottlenecks incurred during the virus recovery step using the eight-plasmid 
system greatly undermined the throughput and reproducibility of these experiments on IAV. 
Techniques, such as the use of helper virus in the viral recovery step, have helped overcome this 
hurdle[101]. This improvement will allow for improved studies on virus function and the 
development of drug resistance.  
 
Scope of thesis 
 In this thesis, I use the EMPIRIC approach, developed in our lab for studying effects of 
mutations on genes, to perform a systematic and comprehensive study of the evolutionary 
constraints shaping the evolution of regions of IAV HA. Specifically, I first study effects of all 
possible single nucleotide mutations in the signal sequence of IAV HA and attempt to elucidate 
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the molecular mechanism of the observed fitness effects. I observe that, on average, synonymous 
mutations in the signal sequence had larger fitness effects compared to a neighboring region of 
HA. Additionally, the signal sequence appears to be more tolerant of non-synonymous mutations 
compared to the neighboring region used for comparison. This observation suggests that 
synonymous substitutions in HA may have greater impacts on IAV evolution than previously 
proposed. Next, I use the EMPIRIC approach to randomize a region near the HA receptor 
binding site and analyze effects of NA enzyme activity on the fitness landscape of this region of 
HA. Most mutations near the receptor binding site of HA were deleterious. However, modulating 
NA activity either by mutation or by adding the NA inhibitor oseltamivir appeared to influence 
the fitness landscape by rescuing defective HA mutations. Inhibiting NA function using 
oseltamivir has an effect great enough to allow the identification of potentially adaptive 
mutations. Modulating NA activity by mutation was not enough to discern HA mutations with 
adaptive potential. This observation underscores the importance of the HA-NA functional 
balance in shaping the evolution of IAV surface proteins. Moreover, these findings highlight the 
need to consider effects of NA inhibitors on HA fitness, and vice versa, on virus evolution and 
therefore drug resistance. 
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Chapter II: Synonymous mutations at the beginning of the influenza A virus hemagglutinin 
gene impact experimental fitness 
This work has been submitted for publication as 
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Abstract 
 
 The fitness effects of synonymous mutations can provide insights into biological and 
evolutionary mechanisms. We analyzed the experimental fitness effects of all single nucleotide 
mutations, including synonymous substitutions, at the beginning of the influenza A virus 
hemagglutinin (HA) gene. Many synonymous substitutions were deleterious in both bulk 
competition and for individually isolated clones. Investigating protein and RNA levels of a 
subset of individually expressed HA variants revealed that multiple biochemical properties 
contribute to the observed experimental fitness effects. Our results indicate that a structural 
element in the HA segment viral RNA (vRNA) may influence fitness. Examination of naturally 
evolved sequences in human hosts indicates a preference for the unfolded state of this structural 
element compared to that found in swine hosts. Our overall results reveal that synonymous 
mutations may have greater fitness consequences than indicated by simple models of sequence 
conservation, and we discuss the implications of this finding for commonly used evolutionary 
tests and analyses. 
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Introduction 
Synonymous mutations change the nucleotide sequence of a gene without changing the 
encoded protein sequence. According to a simple interpretation of the central dogma of 
molecular biology, synonymous mutations do not impact fitness because they do not change 
protein sequences. In this model, all synonymous mutations are neutral or “silent” and the 
evolution of synonymous substitutions is thus determined by mutational processes and genetic 
drift (e.g., the likelihood of different nucleotide substitutions made by replicative polymerases) 
[105]. The availability of a greater number of gene sequences has made it clear that synonymous 
mutations are subject to natural selection [106-109]. 
The signatures of selection acting on synonymous substitutions provide insights into 
evolutionary and biochemical mechanisms. For example, highly expressed genes evolve at a 
slow rate and are preferentially composed of codons that have cognate tRNA at high abundance 
[110-112]. These observations have led to the hypothesis that high expression selects for 
synonymous codons that can be translated efficiently and/or accurately in order to minimize 
fitness costs that scale with expression level [113, 114].  
Despite sequence conservation patterns indicating that natural selection commonly acts 
on synonymous mutations [106], identification of synonymous mutations with measureable 
changes in experimental fitness is rare (e.g., [115]). Many potential explanations could account 
for this apparent discrepancy [116]. These include experimental conditions that do not 
encompass the full breadth of environments encountered in nature [117], non-linear relationships 
between protein function and fitness [118-120], and dramatically different timescales for natural 
selection events to occur compared to the shorter timescales in measuring fitness experimentally 
[116]. For these reasons, when synonymous mutations are made at sites that exhibit strong 
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nucleotide conservation during natural evolution they often do not cause measureable changes in 
experimental fitness [121]. 
Distinct patterns of sequence conservation of synonymous substitutions have been 
observed at the beginning of genes [122, 123]. Rare or non-preferred codons are 
disproportionately observed in the first 90-150 nucleotides of genes. Rare codons at the 
beginning of genes can impact the efficiency of translation initiation and appear to be important 
in regulating the spacing of ribosomes on mRNA [124]. Investigation of the impacts of 
synonymous mutations on GFP expression in bacteria indicated that secondary structure at the 
beginning of the gene has a large impact on the amount of GFP protein expressed [125]. These 
observations motivated us to search for potential experimental fitness effects at the beginning of 
the hemagglutinin (HA) gene of influenza A virus (IAV). 
Because IAV has pandemic potential in the human population [126], a strong interest 
exists in understanding detailed mechanisms of how it can evolve. IAV is a negative-strand RNA 
virus with two main surface proteins, HA and neuraminidase (NA). HA and NA each bind to 
sialic acid but have opposing functions: HA mediates membrane fusion that facilitates viral entry 
[18] while NA cleaves sialic acid on host cells to release newly synthesized virions [127]. HA 
and NA both utilize host machinery for synthesis and trafficking. 
Trafficking of proteins to appropriate cellular compartments is a highly conserved 
process that viruses utilize for propagation in host cells. Signal sequences, located at the N-
terminus of proteins, often serve as molecular addresses for targeting secretory proteins to the 
endoplasmic reticulum (ER) [128-130]. During synthesis of these proteins, which include HA, 
the signal recognition particle (SRP) binds to the signal sequence and mediates co-translational 
trafficking of nascent polypeptide chains to the ER (Fig. 2.1a) [131, 132]. As for many secretory 
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proteins, the signal sequence of HA is cleaved by a host protease and does not form part of the 
mature protein [133-135]. The biochemical mechanisms of HA synthesis are clearly important 
for generating infectious IAV. Yet the sensitivity of IAV infectivity to quantitative changes in 
the efficiency of HA synthesis or the level of HA in viral particles has not been well defined. 
Because the signal sequence is ultimately cleaved off before HA exits the ER, mutations 
introduced into the signal sequence can in principle alter the amount of HA protein generated 
without changing the sequence of the mature HA protein. 
Signal sequences of different proteins often share common biophysical properties. These 
generally include three key features: positively charged amino acids, followed by a hydrophobic 
region, followed by polar amino acids [136, 137]. The signal sequence of HA ranges from 14 to 
17 amino acids in length and contains all three of these features (Fig. 2.1b), but the amino acid 
sequence is generally variable between different HA subtypes (Fig. 2.1c) [138, 139]. Previous 
studies have shown that large deletions in the signal sequence of HA affect protein maturation 
and cellular localization, underscoring this region’s crucial role [140]. However, a systematic 
analysis of the impact of signal sequence mutations on HA synthesis, surface expression, and 
viral function has not been performed.  
Several groups have used deep mutational scanning approaches to study effects of 
mutations on IAV genes, including HA and NA. The Bloom group studied mutational tolerance 
and antigenic evolvability in HA at the amino acid level by calculating the average effect of each 
mutation in a collection of mutants with closely related genetic backgrounds [101, 141, 142]. Wu 
et al. used deep mutational scanning to measure effects of HA single nucleotide mutations on 
viral experimental fitness in order to identify potential targets for vaccine and drug design [143]. 
Both groups used error-prone PCR to perform mutagenesis across the full-length HA protein.  
! 25!
 
Figure 2.1. Function and properties of the signal sequence of HA. (A) Functional illustration. The signal 
recognition particle (SRP) recognizes the signal sequence of nascent HA, initiating the targeting of HA to 
the ER lumen. An ER peptidase cleaves the signal sequence, excluding it from the mature protein that is 
eventually trafficked to the cell surface. (B) Amino acid sequence of the HA signal sequence for 
A/WSN/33 IAV, highlighting the hydrophobic region important for SRP binding and the peptidase cut 
site. (C) Amino acid sequence of the HA signal peptide in different HA subtypes. Consensus sequences 
were generated from 1243 pandemic H1, 1315 non-pandemic H1, 598 H2, 1506 H3, 1585 H5, 1770 H7, 
1168 H9 and 925 H10 sequences retrieved from the Influenza Research Database.  
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It is important to note here that experimental evolution studies investigate the effects of 
mutations in a limited genetic background in a controlled environmental condition. Such studies 
do not perfectly mimic natural evolution where more complex genotypes compete in varying 
environmental conditions and infect different hosts. For these reasons, the conclusions of 
experimental evolution studies should be carefully considered relative to potential distinctions 
with natural evolution. 
In the present study, we used the EMPIRIC (Exceedingly Meticulous and Parallel 
Investigation of Randomized Individual Codons) approach that we previously developed to 
investigate the experimental fitness landscapes of genes [100, 118, 144, 145] to systematically 
investigate the effects of all possible single nucleotide mutations, including all possible 
synonymous mutations, in the signal sequence of HA (Fig. 2.2a). We measured experimental 
fitness which, in our study, represents the replication capacity of each mutant calculated as the 
change in relative mutant frequency before and after bulk competition. The results of our high 
throughput screen indicated that many synonymous mutations cause large experimental fitness 
effects. Using the screen as a guide, we independently analyzed a set of synonymous mutations 
and again observed many large experimental fitness effects. To probe the physical basis of the 
experimental fitness effects, we performed biochemical analyses, including estimates of vRNA 
and mRNA abundance, and efficiency of surface protein expression on a panel of point mutants. 
 
Results 
Quantification of experimental fitness effects of mutations in the HA signal sequence 
We systematically generated and measured the relative effects of each single nucleotide 
mutation to the HA signal sequence in the A/WSN/33 H1N1 strain (Fig. 2.2). A number of 
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mutations were depleted during virus recovery from plasmid and/or during subsequent virus 
infection in the bulk competition assay to the point where the frequency change due to selection 
could not be accurately determined. While these mutations are likely deleterious, they were 
marked as “not determined” in the heatmap (Fig. 2.2b, Supplementary Fig. 2.1) as the severity of 
defects could not be quantified. Extra stop codons were included at elevated frequency in our 
mutant libraries to facilitate quantification of the depletion of null alleles. Using this approach, 
the experimental fitness effects of mutations were quantified on a scale from null (s = -1) to wild 
type (s = 0).  
Experimental fitness measurements during viral infection were generally reproducible 
with an R2 = 0.76 in replicates of the bulk competitions (Fig. 2.2c). This is the range of 
experimental reproducibility seen in similar studies (R = 0.54 to 0.78) using deep mutational 
scanning to study IAV HA [102, 141, 142]. For further validation, experimental fitness effects 
measured in bulk competition were compared to the experimental fitness effects of a panel of 22 
HA variants, including 14 synonymous substitutions, that were randomly picked and individually 
cloned (Supplementary Table 2.1). For this panel of mutants, plaque size was measured as a 
surrogate of fitness, larger plaques being indicative of higher experimental fitness. A correlation 
(R2 = 0.69) was observed between experimental fitness estimates from bulk competitions and 
plaque size measurements (Fig. 2.2d) indicating that our high-throughput experiments provide a 
generally reproducible readout of mutant effects.  
 
Properties underlying selection on the signal sequence of HA 
We examined potential similarities and distinctions in selection acting on the signal 
sequence in our experiments compared with circulating IAV. The experimental fitness effects  
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Figure 2.2. Experimental fitness effects of mutations in the signal sequence of HA. (A) Systematic 
approach to quantify the impact of all single base mutations in the signal sequence of HA on experimental 
fitness. The HA library of single nucleotide mutants was generated on plasmids that were utilized to 
recover viruses, recovered viruses were passaged in MDCK cells, and next-generation sequencing was 
used to estimate the impacts of each mutant on experimental fitness. (B) Heat map representation of the 
observed impacts of mutations in the HA signal sequence. Synonymous mutations are outlined in green 
and the wild type nucleotide at each position is shown by a green dot. (C) Reproducibility of the 
experimental fitness estimates from experimental repeats of the bulk viral expansion. Synonymous 
mutations are shown as circles, non-synonymous mutations as squares and nonsense mutations as 
triangles (R2 = 0.76, P < 0.0001, from linear regression analysis). (D) Correlation between plaque size of 
a panel of mutants measured in isolation and average experimental fitness estimates in bulk competition 
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(n=3, R2 = 0.69, P < 0.0001, from linear regression analysis). Synonymous mutations are shown as circles 
and non-synonymous mutations are shown as squares.  
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measured in A/WSN/33 were compared to mutant frequency in 4374 sequenced, non-pandemic 
H1N1 isolates from the Influenza Research Database [146, 147] (see Methods for details of 
sequence alignment and filtering). Experimental fitness measurements show a rough trend with 
mutant frequency in sequenced circulating viral isolates (Fig. 2.3a & Supplementary Fig. 2.2). 
The experimental fitness effects of mutations observed at least twice in circulating isolates shows 
a narrower distribution compared to mutations that were not observed in circulating isolates (Fig. 
2.3b). There were no mutations observed in circulating IAV that exhibited null fitness in our 
experiments with A/WSN/33, suggesting that similar biophysical properties may mediate 
selection on the HA signal sequence in our experiments and in circulating IAV. At a finer level 
of resolution, many mutations observed in circulating IAV exhibited either apparent fitness 
benefits or defects in our A/WSN/experiments (Fig. 2.3a), indicating that fitness effects of signal 
sequence mutations may depend on genetic background, or environmental conditions, and/or 
noise in our experimental fitness measurements. 
We investigated how biophysical properties previously associated with signal sequence 
function correlate with observed experimental fitness effects. The hydrophobic region of the 
signal sequence serves as the binding site for the SRP and is essential for SRP-mediated 
targeting of nascent proteins to the ER. The relationship between residue hydrophobicity in the 
hydrophobic (h-) region of the signal sequence, quantified using the Kyte & Doolittle 
hydrophobicity score [148], and virus experimental fitness measured in bulk competition was 
analyzed (Fig. 2.3b). Hydrophobicity score in the h-region explains roughly 30% (R2=0.3) of the 
variation we observed in experimental fitness. This correlation is lower than what we observed 
between experimental replicates, indicating that hydrophobicity alone does not fully explain the 
experimental fitness effects. The most hydrophobic amino acid at positions in the h-region did 
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not always provide the greatest experimental fitness, further suggesting selection on additional 
features. While mutations to slightly polar amino acids were compatible with robust 
experimental fitness at some positions, the most polar (least hydrophobic) amino acids were 
consistently strongly deleterious in our experiments. 
Because net hydrophobicity is known to be important for signal sequence function, 
experimental fitness measurements of mutations that introduced charged residues were analyzed 
and compared to uncharged mutations. Charged residues were highly depleted in recovered virus 
despite their high abundance in the plasmid library (Fig. 2.3c). This observation indicates that 
charged amino acids in the hydrophobic region are strongly deleterious, consistent with the 
sparsity of charged amino acids in this region among sequenced isolates [137].  
Previous studies have indicated that small amino acids are strongly preferred at the -1 and 
-3 sites relative to the peptidase cleavage site [134]. We assessed how amino acid size at these 
positions influenced experimental fitness effects. The molecular weight of residues at the -3 and 
-1 positions relative to the peptidase cleavage site had a significant correlation with experimental 
fitness in bulk competition (Fig. 2.3d, R2=-0.36, P=0.02). We note that the strength of this 
correlation is driven by one large amino acid mutation, A17E, that is strongly deleterious. If 
A17E is removed, the correlation is not statistically significant (Supplementary Fig. 2.3). Two 
other large amino acid mutations, T15K and T15R, were severely depleted in recovered virus; 
although precise quantification of their experimental fitness effects is hindered, the depletion 
suggests that these substitutions are also strongly deleterious. While our observations are 
consistent with the -1, -3 rule of preference for small amino acids at these sites relative to the 
peptidase cut site [133, 134], the molecular weight of amino acids near the peptidase cut site only  
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Figure 2.3. Relating experimental fitness with conservation patterns and biochemical properties. (A) 
Comparing experimental fitness measurements to mutant frequency in sequenced circulating viruses. 
Reported P = 0.003 from linear regression. (B) Correlation between experimental fitness measurements in 
bulk competition and the Kyte-Doolittle hydrophobicity scores for residues in the h-region (P < 0.0001 
calculated by linear regression). (C) Box plot showing the frequency of 119 individual mutants in the 
mutant plasmid library before virus recovery and in recovered virus. Mutant frequency for all variants is 
shown in black and the frequency of charged residues is shown in red. P = 0.01 calculated using the 
Mann-Whitney test. (D) Correlation between experimental fitness effect and amino acid molecular weight 
for residues at position 15 and 17, which correspond to the -3 and -1 positions relative to the peptidase 
cleavage site (R2 = 0.36, P value = 0.02 from linear regression).  
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explains part of the observed variance in experimental fitness effects. Other factors including 
structural context may also impact the experimental fitness effects of mutants in this region. 
 
Experimental fitness effects of synonymous substitutions 
Previous studies have found evidence of biased codon usage indicating that synonymous 
substitutions may be under selection for translation efficiency and accuracy [125, 149-153]. In 
our experiments, synonymous substitutions in the signal sequence exhibit a wide distribution of 
experimental fitness effects (Fig. 2.2), with fitness ranging from wild type-like to strongly 
deleterious. To investigate how selection on synonymous mutations may change with distance 
from the beginning of the gene, we used identical EMPIRIC procedures to quantify the 
experimental fitness effects of mutations at amino acids 32-41 of HA1. This 32-41 region is 
located on the HA stem proximal to the HA2 region involved in membrane fusion and is 
generally conserved in group 1 and 2 HA (Supplementary Fig. 2.4). HA is composed of different 
structural and functional domains that are under varying selection constraints. While the amino 
acid 32-41 region of HA does not fully represent the rest of HA, we use it here only as a 
comparison for measuring experimental fitness effects.  
In the environmental condition of our experiment, synonymous substitutions exhibited an 
elevated mean absolute experimental fitness effect in the signal sequence compared to the 32–41 
amino acid region (Fig. 2.4a), though this trend was not statistically significant (P = 0.07) at the 
95% confidence level. However, non-synonymous mutations exhibited higher mean absolute 
experimental fitness effects in the amino acid 32-41 region than the signal sequence region (P = 
0.001) (Fig. 2.4a). Using the ratio in mean absolute experimental fitness effect between non-
synonymous and synonymous mutations as an estimate of the apparent ratio of selection on the 
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protein sequence to the nucleic acid sequence, the signal sequence’s ratio was significantly lower 
than in the amino acid 32–41 region (Fig. 2.4b, P = 0.003). This difference in experimental 
fitness ratio indicates the presence of stronger selection on the protein sequence in the amino 
acid 32–41 region. Our observations are consistent with a combination of stronger selection on 
the nucleic acid sequence, but weaker selection on the amino acid sequence of the signal 
sequence relative to a nearby region of HA. 
Because of variability in our bulk competitions, we pursued independent experiments on 
individual clones to further investigate the fitness effects of synonymous mutations in the signal 
sequence of HA. Consistent with our observations of fitness defects for many synonymous 
mutations from bulk competition, we also observed that many of the synonymous substitutions in 
our panel of individual mutants exhibited diminished plaque sizes relative to the parental strain 
(Fig. 2.4c&d). Both the bulk competitions and the analyses of individual clones indicate that 
synonymous mutations in the beginning of the HA gene caused measureable defects in 
experimental fitness. 
To further investigate potential differences in the experimental fitness effects of 
synonymous mutations, infection kinetics experiments were performed on four synonymous 
substitutions, L5LCTC, L6LCTC, L6LTTG and L8LCTA picked from the panel of individually cloned 
mutants. Three of these mutants exhibited growth defects in bulk competition (L6LCTC, L6LTTG 
and L8LCTA), while L5LCTC did not exhibit a growth defect in bulk competition (Fig. 2.2). As 
individual mutants, each of these four mutants exhibited right-shifted infection growth kinetics 
relative to wild type virus (Fig. 2.4e&f).  
It is challenging to directly compare the infection kinetics results with the bulk 
competition data and to reconcile differences in results because of distinctions in the inherent  
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Figure 2.4. Synonymous mutations impact experimental fitness in the signal sequence of HA. (A) 
Beeswarm plot comparing the mean of absolute experimental fitness effects of synonymous and non-
synonymous mutations in the signal sequence and in a region of HA encoding amino acids 32–41. The y-
axis represents the magnitude of the experimental fitness effect from wild type (fitness = 0). Error bars 
represent the standard error of the mean and reported P value from multiple comparison analysis test. (B) 
The apparent ratio of selection acting on non-synonymous/synonymous mutations calculated as the ratio 
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between mean absolute experimental fitness effects of non-synonymous and synonymous mutations. 
Error bars are based on propagation of standard errors of the means and reported P value from Student’s 
t-test. (C) Average plaque size measured for a panel of individually cloned synonymous mutations. Error 
bars represent standard error of the mean. (D) Images for plaques of wild type virus and 2 synonymous 
substitutions (L6LCTC and L8LTTG) that were found to have experimental fitness defects. (E) Infection 
kinetics of wild type IAV and four variants carrying synonymous mutations in the signal sequence of HA. 
Titer was determined based on replicate plaque assays (n=2) and the error bars represent the difference 
between the two assays. (F) Comparison of viral titer on a linear scale at t = 12 h during the infection time 
course. P values from multiple comparison analysis test. 
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experimental design. In the EMPIRIC experiments, multiple viral mutants are competing against 
each other, while the infection kinetics experiments follow the expansion of a single viral clone. 
The host cells available for infection over time likely differ in each of the two types of 
experiments. To try to account for these distinctions, we compared EMPIRIC selection 
coefficients with either the viral titer at 12 h or the change in titer between 6 and 24 h from the 
kinetic experiments and observed poor correlations in both cases (Supplementary Fig. 2.5a&b). 
While we were not able to develop a simple and effective comparison between the results of the 
bulk competitions and the kinetics analyses, we noted distinctions in the kinetic behavior of 
specific mutants. For example, the L5LCTC mutant that did not show a growth defect in the bulk 
competition and had a low titer at 12 h but exhibited the most rapid expansion between 6 and 24 
h in the kinetic experiments. 
The discrepancy between the infection kinetics assay and bulk competition 
(Supplementary Fig. 2.5b) could also be due to inherent challenges in measuring experimental 
fitness effects with precision using these techniques. Consistent with our analyses of the 
reproducibility of experimental fitness measurements, it appears that our experiments can 
distinguish overall trends but are not precise enough to discern the effect of individual mutations 
with great confidence. For this reason, we have taken multiple approaches to investigate 
experimental fitness effects, as each approach has caveats. The slowed infection kinetics of three 
individual mutations that were deleterious in the bulk competitions lends evidence that 
synonymous mutations in the signal sequence can cause strong defects in viral expansion. 
To further investigate the kinetic expansion results, a phenomenological 5-parameter 
model of IAV growth kinetics [154] was used to fit the experimental data (see Methods and 
Supplementary Information for details). Sensitivity analysis of the model showed that only two 
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parameters (β and τE) could be reliably estimated (Supplementary Fig. 2.6). The β parameter 
describes the rate of infection of target cells. The τE parameter represents the average duration of 
an eclipse phase, which is the time cells are infected before virus is produced (see Methods and 
Supplementary Fig. 2.6, 2.7 for details). Consistent with the infection kinetics data, L5LCTC, 
L6LCTC, and L8LCTA demonstrated a delayed eclipse phase along with an increased infection 
rate. The L6LTTG mutant demonstrated WT-like kinetics of viral replication in this model (Table 
2.1). 
 
Signal sequence mutations may affect viral RNA structure 
It has been reported previously that the folding free energy of a 42-nucleotide long region 
beginning four nucleotides before the start codon of both bacterial and eukaryotic mRNA affects 
translation initiation efficiency [155, 156]. Additionally, in the influenza virus, packaging signals 
in HA segment vRNA span the 5’ UTR and extend for up to 45 nucleotides in the HA ORF [157, 
158]. Therefore, synonymous mutations in the 5’-end region of the HA segment, which includes 
part of the signal sequence, can be expected to alter HA expression efficiency as well as vRNA 
packaging. To investigate the relationship between possible defects in viral RNA and 
experimental fitness, the folding free energy, ΔG, of secondary structures of both mRNA and 
vRNA in the 5’ region (sense) for all synonymous HA variants was estimated using the 
ViennaRNA software [159] (Supplementary Fig. 2.8a). Local secondary structure of RNA was 
probed by restricting the sequence lengths for folding to fixed windows of several tested sizes: 
24, 36, 42, 54 and 62 nucleotides. Analysis of the correlation between experimental fitness and 
ΔG for different window sizes and positions (Supplementary Fig. 2.8B) showed a statistically 
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significant correlation between experimental fitness and ΔG for a window of size 24 nucleotides 
beginning at nucleotide 6 in vRNA (permutation test, see Methods). 
No significant correlation between the energy ΔG of mRNA structure in the HA signal 
sequence and experimental fitness was observed. Analysis of predicted vRNA structure at 
positions 6–30 revealed a small hairpin at positions 7–23 (Fig. 2.5a). The energy ΔG of mutant 
vRNA in this region has a bimodal distribution, with peaks around -4 kcal/mol (stable hairpin) 
and -1 kcal/mol (hairpin unfolded) (Supplementary Fig. 2.9). Mutant viruses predicted to be 
unstructured in this region exhibited a higher mean experimental fitness compared to viruses 
predicted to have an intact hairpin (Fig. 2.5b). While this trend was not statistically significant (P 
= 0.29), it suggests that less structured vRNA in this window may be beneficial for virus 
replication under our experimental conditions. 
To check for similar findings in sequenced HA of circulating IAV, we evaluated HA 
sequences from the Influenza Research Database [146, 147]. Targeted RNA folding for the 30 nt 
region beginning at position 6 at the 5’ end of HA segment in the vRNA was performed and the 
occurrence of different RNA secondary structures in the region was analyzed for strains isolated 
from either human or swine hosts (Fig. 2.5c). A two-sample Kolmogorov-Smirnov test indicates 
that the distributions of RNA folding energy for human-derived and swine-derived IAV are 
different (P < 0.01). While viruses from both human and swine are bimodal with peaks at ≈-0.5 
kcal/mol and ≈-4 kcal/mol, the human viruses have a higher peak for the unfolded state 
compared to the swine viruses. These observations are consistent with selection favoring the 
folded RNA state in swine hosts relative to human hosts. 
To investigate relationships between RNA structure and function, we analyzed the 
structures formed by the stable RNA state. Nearly 90% of the structures with the energy of ≈-4  
! 40!
 
Figure 2.5. Probing effects of mutations on viral RNA. (A) Illustration of the hairpin at nucleotide 
position 7–23 in the HA vRNA. (B) Comparing experimental fitness of mutations that disrupt the hairpin 
at nucleotide 7–23 to mutations that leave the hairpin intact (P>0.62 calculated using the Mann-Whitney 
test). (C) Frequency distribution of calculated !G for sequenced IAV isolated from either human (top 
panel) [160] or swine (bottom panel) hosts.  
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kcal/mol have similar hairpin folds centered around a 5-nucleotide long loop at nucleotides 13 to 
17 (or 3-nucleotide loop at positions 14 to 16), such as shown in Fig. 2.5a. We extracted the  
sequences of the 5-nucleotide loop from sequences of circulating strains that have the stable 
hairpin, and compared sequence occurrence with experimental fitness values in our bulk 
competition experiment. The sequence variants present in circulating HA all have WT-like 
experimental fitness, while assayed sequences that are not found in the database all have an 
experimental fitness defect (Supplementary Table 2.2). This observation indicates that EMPIRIC 
fitness measurements for this region are in agreement with trends seen in sequenced natural 
isolates. Additionally, it implies that the hairpin/loop may be important for viral fitness under 
specific conditions (e.g., when infecting a swine host), similar to the previously reported 
packaging interactions between vRNA hairpins of IAV segments 2 and 8 that encode the RNA 
polymerase subunit PB1 and non-structural protein (NS), respectively [161].   
To assess the effects of signal sequence mutations on vRNA packaging, RT-qPCR was 
used to measure HA vRNA abundance for a panel of individual cell-free mutant viruses. HA 
vRNA levels were normalized to NA vRNA and used to quantify the packaging efficiency. No 
strong correlation was found between the efficiency of packaging HA vRNA into particles and 
EMPIRIC fitness (Supplementary Fig. 2.10). This lack of correlation reveals that viral expansion 
under our experimental conditions may not be tightly coupled to packaging efficiency, or that we 
are unable to capture that relationship at our current experimental precision. However, all of the 
signal sequence mutations analyzed reduced the efficiency of HA vRNA packaging into 
particles, indicating that the wild type signal sequences facilitate highly efficient packaging. 
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Signal sequence mutations influence HA protein abundance in viral particles 
Because the HA signal sequence is cleaved and excluded from the mature protein, 
mutations in this region are likely to affect HA synthesis efficiency and expression rather than 
the ultimate function of the HA protein. ELISA was used to quantify HA protein expression for a 
panel of individual mutations to examine how signal sequence mutations impact HA protein 
abundance in cell-free viral particles (Fig. 2.6a, see Methods). All of the studied mutations 
precede the peptidase cleavage site located at amino acid 17, so mutations would result in 
identical mature HA protein. Optimal virus experimental fitness, measured in bulk EMPIRIC 
competition, was supported by a narrow range of HA expression – either too much or too little 
HA was associated with experimental fitness defects (Fig. 2.6b). The relationship between HA 
abundance and viral experimental fitness was nonlinear with R2 = 0.4 and P = 0.007, and appears 
to be under stabilizing selection. Of note, we excluded L8LTTG from the fit because its expression 
level is far removed from all other points. Nevertheless, the relationship is still statistically 
significant even if L8LTTG is included (P < 0.05). 
 
Changes in HA synthesis efficiency partly explain experimental fitness effects 
To measure effects of signal sequence mutations on HA synthesis in the absence of other 
viral RNA segments, HA was transiently expressed in 293T cells and HA synthesis quantified by 
flow cytometry (Fig. 2.7a, see Methods for details). Non-synonymous substitutions had lower 
HA expression levels compared to the wild type, while synonymous mutations either reduced or 
increased HA expression. Additionally, a statistically significant correlation was found between 
HA abundance and experimental fitness effects measured in bulk (Fig. 2.7b, P = 0.0002).  
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Figure 2.6. Relationship between experimental fitness and relative HA protein in cell-free viruses. (A) 
Experimental setup: viral particles were adhered to wells in plastic plates and HA abundance was 
quantified by ELISA. (B) Comparison of mutant impact on experimental fitness and HA abundance. 
Synonymous mutations are shown as circles and amino acid changing mutations as squares. The 
synonymous mutation of L8L (TTG), shown in grey, is excluded from the fit. R2 = 0.4 and P value = 
0.007 calculated by quadratic nonlinear fit.  
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To further discern whether experimental fitness effects arise from inherent defects in HA 
synthesis or from HA expression on virus particles, HA expression in 293T cells and HA  
abundance in viruses was compared. A significant correlation was found between HA synthesis 
and HA expression in virus particles (Fig. 2.7c, P < 0.0001). However, four synonymous  
mutations (L6LCTC, V7VGTG L8LTTG and A11AGCG) deviated far from the trend. The frequency 
of these variants in sequenced non-pandemic H1N1 isolates was analyzed and despite being 
synonymous substitutions, these variants are rare in circulating viruses. This observation 
suggests the importance of the nucleotide sequence in this region for virus function. When 
compared to wild type, these variants had wild type-like or reduced levels of HA expression in 
293T cells, but had up to three times as much HA per plaque forming unit (PFU). These 
observations are consistent with an increased ratio of non-infectious to infectious particles, 
though further confirmatory studies would be required. 
 
Multiple linear regression analysis of experimental fitness effects 
To identify measurable factors affecting bulk experimental fitness of IAV mutants, 
multiple linear regression analysis was performed. As discussed above, the viral experimental 
fitness determined in the EMPIRIC experiments is correlated with various metrics of HA in 
vitro, using either a linear or quadratic model, see Figures 2.6b and 2.7b correspondingly. To 
assess whether additional factors explain the observed variance of experimental fitness, a linear 
regression model was used with HA synthesis in mammalian cells, HA protein abundance in 
cell-free viral particles, and mRNA folding energy !G as explanatory variables. The 
combination of HA synthesis in mammalian cells and HA protein abundance in cell-free viral 
particles improved the prediction of experimental fitness, R2 = 0.68; ANOVA comparison of the  
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Figure 2.7. Relationship between experimental fitness and HA protein expression. (A) HA was expressed 
in 293T cells and HA protein expression was measured by flow cytometry. (B) Comparing experimental 
fitness to HA expression in 293T cells. P value calculated from linear regression. (C) Comparison of HA 
protein abundance in cell free viruses to HA expression in 293T cells (reported P value from linear 
regression). The points in grey exhibit the largest discrepancy between observed abundance in viruses and 
293T cells and are omitted from the fit.   
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models yielding P = 0.014. The best prediction was achieved by a linear model combining all 
three factors, HA protein synthesis, HA abundance in released virus, and mRNA ΔG, yielding R2  
= 0.752, and marginally significant P = 0.053 for ANOVA comparison of the 2 vs. 3 factor 
models. The complete set of P-values of nested linear regression models is presented in  
Supplementary Table 2.3. The folding energy of mRNA was defined as the free energy !G of the 
viral mRNA segment consisting of nucleotides -4 to 37 relative to the HA start codon, as 
described in [140]. Adding a categorical variable representing DNA library comprising a 
particular mutant did not improve the fit, suggesting the measurements were not characterized by 
batch effect. Likewise, inclusion of additional metrics such as HA vRNA abundance normalized 
to NA viral RNA, vRNA !G, and position of the mutation did not improve the predictive power 
of the multiple linear regression model for experimental fitness (data not shown). However, the 
effectiveness of additional predictors in the multiple regression was also limited by the overall 
number of available data points. 
These results suggest that the experimental fitness of synonymous mutants in IAV HA is 
affected by multiple factors including RNA secondary structure, protein synthesis and surface 
expression as well as functional interactions between the viral and host components. 
 
Discussion 
Our bulk competitions indicate increased selection on synonymous mutations in the 
signal sequence relative to a nearby region of the HA gene. Consistent with this idea, many 
individual synonymous mutations in this region caused defects in viral infectivity when analyzed 
in isolation. The finding that synonymous mutations in the signal sequence affect viral fitness 
agrees with previous studies that showed that synonymous mutations in the beginning of genes 
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can have large impacts on translation efficiency [125, 149, 156]. Biochemical analyses of a panel 
of synonymous mutations revealed that variants with reduced HA expression had lower 
experimental fitness, suggesting selection on the efficiency of protein synthesis. Signal sequence 
mutations also appeared to impact HA protein levels in viruses and during expression in the 
absence of other IAV genes in 293T cells. Our results are in agreement with selection against 
reduced HA expression that may in turn impact the ratio of infectious to non-infectious particles 
leading to apparent stabilizing selection on HA abundance per infectious particle. Yet the 
impacts of synonymous substitutions on translation efficiency appear to only partly explain the 
experimental fitness effects that we measured. 
Changes in vRNA structure also explain some of the experimental fitness effects of 
synonymous substitutions. We found that change in RNA folding energy in a 24 nt window at 
position 6 is correlated with experimental fitness. Our analyses also indicate that the hairpin loop 
at position 7–23 may have structural significance as mutations that disrupted this hairpin loop 
had higher average experimental fitness in our experiments compared to mutations that left the 
hairpin loop intact. Intriguingly, clustering of HA sequences from circulating IAV based on the 
existence of the hairpin loop revealed correlations with the host (swine versus human), in line 
with earlier reports of lineage specificity of RNA structure in IAV segments [162-164]. This 
variability in structural features across different IAV strains and lineages may be responsible for 
the lack of conserved secondary structures in IAV vRNA, as proposed by previous genome wide 
computational analysis [165].  
The panel of individual mutations analyzed experimentally caused a reduction in the 
levels of HA vRNA in virus particles compared to the wild type. This observation further 
supports the importance of the 5’ UTR in packaging of functional IAV virus [157, 158]. Features 
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beyond hairpin or unfolded conformations in this region may also be important for experimental 
fitness. While future studies will be required to understand these details further, we note the 
presence of binding interactions similar to previously reported hairpin interactions between 
vRNA of segments PB1 and NS [161]. While the correlation between mRNA folding free energy 
and experimental fitness was not statistically significant, single nucleotide synonymous 
mutations in the signal sequence may introduce subtle structural changes that are poorly resolved 
by mRNA folding models and also poorly captured by a thermodynamic metric such as ΔG. 
The effects of non-synonymous mutations on virus experimental fitness are generally 
consistent with the previously established biochemical properties of the signal sequence. Our 
results support the importance of hydrophobicity in the signal sequence [130, 137], and the 
importance of small amino acids near the protease cut site [133, 134]. Amino acid changes that 
introduce charged residues in the hydrophobic region or bulky residues near the protease cut site 
showed deleterious effects, indicative of structural and functional constraints on the amino acid 
sequence to ensure binding by the SRP. However, when compared to a region outside the signal 
sequence (amino acids 32–41), non-synonymous mutations have higher mean absolute 
experimental fitness effect suggesting that selection at the amino acid level is weaker in the 
signal sequence relative to this nearby region. This pattern agrees with previous reports that the 
amino acid sequence of the signal peptide of secretory proteins evolves up to five times faster 
than other regions [166, 167]. 
The biochemical underpinnings of selection on the signal sequence appear complex. 
Interestingly, we find measurable experimental fitness effects of synonymous mutations in the 
nucleotides encoding the HA signal peptide— a finding supported by the analysis of sequences 
from natural isolates as well. Our results demonstrate that selection acting on the signal sequence 
! 49!
is due to multiple biochemical pressures, including constraints on RNA secondary structure, 
RNA packaging efficiency, protein synthesis and trafficking. This type of selection produces a 
pattern of sequence evolution that is not readily identified by simple models of conservation. 
Specifically, our findings indicate that patterns of conservation in natural populations only reveal 
a fraction, perhaps only the tip of the iceberg, of the impacts that synonymous mutations can 
have on fitness. This result holds important implications for commonly used dN/dS (i.e., the ratio 
of non-synonymous to synonymous divergence) based statistics used for analyzing the selective 
pressures facing populations. Namely, the fundamental assumption of these approaches is that 
synonymous mutations are neutral with respect to fitness, and thus dS represents the rate of 
fixation owing to genetic drift alone (which is simply equal to the mutation rate). dS is then 
compared with dN, where a ratio larger than 1 is interpreted as evidence of positive selection on 
non-synonymous mutations. However, if synonymous mutations are indeed non-neutral as these 
results suggest, the rate of fixation of synonymous sites is no longer an appropriate proxy for 
neutrality, potentially resulting in dN/dS ratios that are greatly misleading. Thus, future 
experimental studies aimed at better defining the impacts of synonymous mutations on pathogen 
fitness and correlations with RNA structure will be of interest, in particular in pathogens with 
error-prone polymerases. 
 
Materials and methods 
Engineering plasmid libraries 
Systematic single nucleotide mutant libraries of the signal sequence of HA were generated in 
reverse engineered IAV strain WSN/33 as previously described [100, 144]. Briefly, nucleotides 
encoding amino acid 1 to 1650 of HA were transferred to the pRNDM plasmid [144] and 
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mutations were introduced using a cassette ligation strategy. In addition to single nucleotide 
mutants, we included additional stop codons at an elevated abundance as an internal control in 
anticipation of potentially strong selection that might otherwise be difficult to detect. Mutant 
libraries were transferred to the pHW2000 plasmid [168] using an engineered destination vector 
and Gibson Assembly (New England Biolabs) as described [169]. 
 
Cell culture and viral recovery 
MDCK and 293T cells were used for viral recovery and passaging as previously described [170]. 
Viruses were generated using the pHW2000-based 8 plasmid system using plasmids and protocol 
developed by Webster and colleagues [168]. Briefly, 1 µg of HA plasmid library and 1 µg of 
each plasmid encoding the rest of the A/WSN/33 genome, were transfected in a co-culture of 
MDCK and 293T cells using TransIT LT1 reagent (Mirus, Madison, WI). Cell growth media 
was changed to serum-free media 6 h post-transfection. TPCK trypsin (Sigma-Aldrich, St. Louis, 
MO) was added to a final concentration of 0.5 µg/mL 30 h post-transfection. At 72 h post-
transfection virus-containing supernatant was harvested, centrifuged at 300g for 15 minutes and 
stored at -80 °C. Viral titer of the recovered viruses was quantified by plaque assay as previously 
described [170]. Briefly, 10-fold serial dilutions of virus-containing supernatant were added to 
confluent MDCK cells and allowed to bind for 1 h at 37 °C. Unbound viruses were washed off 
with PBS and infected cells were overlaid with 0.5% agar in DMEM and incubated at 37 °C. 
Plaques were immunostained with antibody against IAV NP and visually counted 48 h after 
infection. 
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Bulk competition experiments 
Competition experiments were conducted as previously described [170]. Briefly, MDCK cells 
were plated at 106 cells per well in 6-well plates the day before infection. Cells were then washed 
with PBS followed by cDMEM Dulbecco's modified Eagle's medium, 100 U/mL penicillin, 100 
µg/mL streptomycin, and 7.5% bovine serum albumin. Recovered viruses were diluted in 
influenza virus growth medium (cDMEM/ BSA with 1 µg/mL TPCK trypsin) and infections 
were performed in triplicates at a multiplicity of infection of 0.01. Cells were incubated with 
virus for 1 h at 37°C. Unbound virus was washed off twice with PBS. Infected cells were grown 
in influenza virus growth media at 37 °C. Virus-containing supernatant was collected 48 h post-
infection and stored at -80 °C. 
 
Quantification of mutant abundances 
Mutant abundance was quantified as previously described [170]. Briefly, virus-containing 
supernatant was treated with DNase (New England BioLabs, Ipswich, MA) for 1 h at 37 °C for 
degradation of plasmid DNA. Influenza viral RNA was extracted using the QIAamp Viral RNA 
minikit (Qiagen, Germantown, MD). cDNA was generated using HA-specific RT primers and 
SuperscriptIII (Life Technologies, Beverly, MA). Sample processing for sequencing was 
performed as previously described [144]. Briefly, PCR was used to introduce cut sites for 
ligation of sample-specific adapters. Adapter-ligated samples were quantified, pooled and 
submitted for analysis of mutant abundance by Illumina single read 36-bp sequencing on a 
Genome Analyzer II. Reads with greater than 99.5% confidence were analyzed. Relative mutant 
abundance was calculated as log2(
!"#$%#&' ). Analyzing changes in mutant frequency between the 
plasmid library and recovered viral population provided an estimate of selection during viral 
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recovery. Experimental fitness effect in bulk competition was calculated as the difference in 
relative mutant abundance before and after competition.  
 
Growth analyses of individual mutants 
Twenty-two individual mutants (Supplementary Table 2.1) were cloned and recovered as 
described for mutant libraries. The viral titer for each variant was determined by plaque assay. 
Images of plaques were acquired using a Nikon SMZ1500 microscope. For each mutant, we used 
the NIS Elements-BR Analysis program to measure the diameter of 10–20 randomly selected 
plaques. The average plaque size for each mutant was calculated and utilized as an estimate of 
the growth rate. Viral infection kinetics for a subset of mutants were determined by infecting 
MDCK cells at a multiplicity of infection of 0.01, as described earlier, and collecting virus-
containing supernatant at 6, 12, 48 and 72 h post infection. Viral titer analyzed by plaque assay 
was used to measure viral amplification over time in these experiments. 
 
Investigating the relationship between vRNA/mRNA structural variation and observed 
experimental fitness effects of synonymous substitutions 
Predicted Minimum Free Energy (MFE) of RNA secondary structure was used to test the 
connection between observed synonymous experimental fitness effects and local structural 
variation in the mRNA/vRNA of mutated HA segments. MFE was calculated for the 
synonymous HA mutations in a window of size W, sliding across the first 80 nt (30 nt UTR and 
50 nt CDS) of the HA mRNA/vRNA sequence. The Pearson correlation coefficient R was used 
to quantify the relationship between calculated MFE values and measured experimental fitness 
effects. To assess the statistical significance of this correlation, a random permutation test was 
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used, permuting the energy !G and experimental fitness for each window, window size and 
position (Supplementary Fig. 2.8). Regions of mRNA/vRNA demonstrating significant (P ≤ 
0.05) correlation between experimental fitness and MFE were subjected to additional criteria: (1) 
we set a lower limit of 10 for the number of measured experimental fitness values per folding 
window, as the number varied with size and starting position of the window (2) standard 
deviation of predicted MFE values per folding window was limited from below (σ≥1), to ensure 
sufficient structural variation in the window. Biological relevance of the regions with the 
significant correlation and both additional criteria satisfied was further investigated. The 
described analysis was performed independently for mRNA and vRNA sequences, with window 
sizes W (W=24,36,42,54,62 nt). As described by [125], we used a zero-based numbering of 
nucleotides in the mRNA and vRNA. The RNAfold program from the ViennaRNA 2 software 
package [159] was used for RNA folding with the default settings applied. 
 
Alignment of naturally occurring HA sequences 
We downloaded 4452 coding sequences (CDS) of HA segment from the NIAID Influenza 
Research Database (IRD) [147] using only H1N1 strains and excluding overrepresented 
pandemic H1N1 from the year 2009. HA sequences of sufficient length (> 50 nt) were aligned 
using TranslatorX [139], which aligns sequences of translated amino acids first and then 
translates back the amino acids using initial codons. The multiple sequence alignment was 
further filtered in order to eliminate HA sequences with insertions and deletions in the first 100 
nt near the 5’ end, resulting in 4374 HA sequences. 
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Analysis of structural variation of mRNA/vRNA in the naturally occurred HA variants 
We focused on nucleotides 6 to 30 of the sequences retrieved from the IRD, a region that appears 
biologically relevant according to our experimental and statistical analysis of WSN/33 H1N1 
strain. To test if the predicted hairpin was still supported by the naturally evolved sequences we 
folded a wider region of vRNA 0-36 nt, while restricting the size of secondary structure to 24 nt. 
 
The RNAfold program from the ViennaRNA 2 software package was used for RNA folding with 
the maxBPspan parameter set to 24 nt and otherwise default settings applied otherwise. All 
statistical testing and visualization was performed using custom Python scripts, available at 
https://github.com/sergpolly/EMPIRIC-HA and upon request. 
 
Measuring HA protein abundance in viral particles 
Indirect enzyme-linked immunosorbent assay (ELISA) was used to quantify HA abundance in 
cell free viral samples. Mutations L9LTTG, L9LCTA, A11AGCT and V13VGTC were added to the 
above panel for analysis. Recovered viruses were diluted in coating buffer (3.03 g Na2CO3; 6 g 
NaHCO3; 1 L distilled water; pH 9.6; sterile filtered) and 104 plaque-forming units per well were 
incubated in 96-well MaxiSorp plates overnight at 4 °C (Sigma-Aldrich, St. Louis, MO). 
Unbound virus was removed and wells were blocked with 5% BSA in PBS for 1 h. Primary 
antibody, influenza A virus H1N1 HA antibody (Genetex, Irvine, CA. Cat.no GTX 127357), was 
added and incubated on a rocker at room temperature for 2 h. Wells were washed and incubated 
with sheep anti-mouse IgG HRP-conjugated secondary antibody (General Electric, UK Limited) 
for 1 h at room temperature. Wells were washed again and HRP substrate (ThermoFisher 
Scientific, Waltham, MA) was added to wells and incubated in the dark at room temperature for 
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30 minutes. 2 M phosphoric acid was added to stop the reaction. Absorbance was measured at 
450 nm on a SpectraMax PLUS plate reader (Molecular Devices, Sunnyvale CA). For each viral 
stock, three ELISA replicates were performed. 
 
Measuring HA expression in mammalian cells 
In order to measure HA expression, the above panel of HA variants was cloned into the JB991 
plasmid, kindly provided by J. Bloom (Fred Hutchinson Cancer Research Center, Seattle), that 
has a GFP reporter, an ampicillin resistance gene, and a CMV promoter. These constructs were 
transiently expressed in 293T. Cells were washed and re-suspended in isotonic buffer (15 mM 
MOPS, 145 mM NaCl, 2.7 mM KCl, 4 mM CaCl2 pH 7.4. 2% heat-inactivated FBS added 
immediately before use). HA primary antibody (Genetex, Irvine, CA. Cat. no GTX 127357) was 
added to cells and incubated for 1 h at room temperature. Excess antibody was washed off twice 
with isotonic buffer. Alexa Fluor 647 goat anti-rabbit IgG secondary antibody (ThermoFisher 
Scientific, Waltham, MA) was added and incubated at room temperature for 1 h. Cells were 
washed, re-suspended in isotonic buffer and analyzed on a BD FACSCalibur. Data analysis was 
conducted using the FlowJo data analysis software package (Ashland, OR). 
 
Quantification of vRNA levels 
To measure effects of signal sequence mutations on viral RNA, virus-containing supernatant was 
treated with DNase for 1 h at 37 °C. Total viral RNA was extracted for each mutant variant using 
the QIAamp Viral RNA minikit (Qiagen, Germantown, MD). In separate reactions, cDNA was 
generated using HA- and NA-specific RT primers and Superscript III (Life Technologies, 
Beverly, MA). This cDNA was then used as template in qPCR performed using SYBR Green 
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and HA- and NA-specific PCR primers (ThermoFisher Scientific, Waltham, MA) on an 
Eppendorf MasterCycler RealPlex machine (Eppendorf). Relative HA vRNA abundance was 
calculated using the efficiency-corrected approach developed by Pfaffl [171] and normalized to 
NA vRNA. 
 
Modeling of the growth parameters of individual mutants 
We used a multi-compartment ordinary differential equation (ODE) model [154, 172] to 
compare viral yield kinetics of silent HA mutants. In the model, initial infection )*+,(0) spreads 
in a population of / susceptible target cells (0), and infects cells at a rate 1)*+,(2). Infected 
cells spend on average 34 time in an eclipse phase (5) and then, upon switching into infectious 
mode (6), start producing virus at a rate 7 for average duration of 38. Newly generated virus 
contributes to the total viral pool )*+,(2) that supports the spread of infection, and also degrades 
at a rate 9. We exclusively considered infectious particles (PFU) in this model, neglecting ):;<(2) (for which we have no data) in the ODE system (Eq. 1 from [154]) and fit the 
experimental data by minimizing the log-scaled sum of squared residuals (SSR) between 
experimental measurements and simulated ones for a set of model parameters = =(1, 34, 38, 7, 9):  
@@A(=) = logEF)G − logEF)*+,(2G, =) IJKLMGNE , 
where OPQR is the number of PFU measurements per mutant and )G are values of PFU measured 
at 2G =6, 12, 24, 48, 72 h. The number of compartments is fixed in our simulations S4 = S8 =20. The size of initial target cell population was / = 10V, with MOI= 10WX. Supplementary 
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Figure 2.4 shows example of the viral growth measurements and the model fit with optimal 
parameters. Following Paradis et al. [154], the odeint function from scipy was used to solve the 
ODE system and the emcee python module was used to perform Markov Chain Monte Carlo 
(MCMC) simulations to extract the probability distribution of the model parameters. Initially we 
found an optimal set of parameters = = (1, 34, 38, 7, 9) for each mutant and then performed 
MCMC simulation using 100 walkers for 1000 steps. Upon convergence, data from step 600 and 
beyond was used to estimate the probability distribution, see Supplementary Figure 2.7. In order 
to assess the difference between estimated distributions, A and B, we used 7-values derived from 
a two-sample Y-test, Z
Y = [< − [\]<I + ]\I, 
where for a given parameter and mutant, [ is the mean of the distribution and ] is its standard 
deviation. We used logEF of the 1 infection rate parameter for placing confidence limits on the 
estimated model parameters. 
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Tables 
Table 2.1. Viral growth kinetics parameters estimated for wild type and 4 silent HA mutants, 
described by rate of infection of target cells ", and duration of eclipse phase τE. Median values 
and 95% bootstrap confidence intervals (BCI) are shown.  
 Log10 ",Z[95% BCI] 34, [95% BCI] 
WT 
L5LCTC 
L6LCTC 
L6LTTG 
L8LCTA 
-6.28, [-6.50 -6.05] 
-4.97, [-5.26 -4.69] 
-4.85, [-5.10 -4.58] 
-6.16, [-6.40 -5.87] 
-5.11, [-5.30 -4.92] 
6.16, [5.82 7.64] 
20.8, [19.0 22.3] 
18.8, [17.1 20.0] 
8.82, [7.52 10.9] 
23.1, [22.0 24.0] 
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Supplementary Figure 1. Box plot showing the frequency of undetermined variants in the plasmid 
library and in recovered virus (n=35).
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Supplementary Figure 2. Comparing absolute experimental fitness effects with mutant frequency in
sequenced circulating viruses.
p value < 0.001
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Supplementary Figure 3. Relationship between measured experimental fitness effects and 
amino acid molecular weight at positions -3 and -1 relative to the peptidase cleavage site 
excluding the mutation A17E.
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Supplementary Figure 4. Sequence conservation for the amino acid 32–41 region in different 
HA subtypes.
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Supplementary Figure 5.  Comparing mutant fitness in bulk competition and replication kinetics
of individual mutants in isolation. (A) Comparing mutant fitness in bulk competition and viral 
titer at 12 hpi (pfu/ml) from replication kinetics assay of individual mutant viruses. 
(B) Comparing mutant fitness in bulk competition and the rate of increase in titer (pfu/ml/h) of 
individual mutants.
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Supplementary Figure 7. Distributions of the kinetic model parameters β, τE, τI, p ,c estimated for the L8LCTA 
mutant using MCMC simulations of the ODE kinetic model of IAV infection. The MCMC simulation samples the
 parameter space, generating an estimate of the probability distribution for the parameters that minimize 
SSR(Θ = (β, τE, τI, p ,c)). The plots on the diagonal represent the probability distributions of the five 
individual parameters (β, τE, τI, p ,c). Qualitatively, the distributions of the parameters β and τE  (rate of 
infection and duration of the eclipse phase, respectively) exhibit a sharp response in the model fit and were
 selected. The quality of model fit was much less sensitive to the changes of the other three parameters. The 
off-diagonal panels represent the joint parameter distributions for pairs of parameters, with darker shades
 of blue corresponding to a higher probability density.
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Supplementary Figure 9. Comparing experimental fitness and RNA folding free energy ΔG. vRNA
 was folded at positions 6-30.
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Supplementary Figure 10. Relationship between changes in HA vRNA levels normalized to NA
(WT = 1) and experimental fitness measured in bulk competition.
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Mutation Codon 
K2K 
A3E 
A3T 
K4R 
L5L 
L5L 
L6L 
L6L 
L6L 
V7V 
L8L 
L8L 
Y10N 
A11A 
A11A 
A11S 
A14A 
T15I 
T15T 
D16H 
A17A 
A17E 
AAA 
GAA 
ACA 
AGA 
CTC 
CTT 
CTC 
CTT 
TTG 
GTG 
CTA 
TTG 
AAT 
GCC 
GCG 
TCA 
GCC 
ATA 
ACT 
CAT 
GCG 
GAA 
Supplementary Table 1. Panel of mutations analyzed in isolation. 
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Loop EMPIRIC fitness Count in fludb 
AUGAC 
ACGAC 
AUUAC 
AGGAC 
AAGAC 
AUGAG 
AUGAA 
AUAAC 
(wt)0.00 
0.22 
ND 
0.31 
-0.11 
-0.55 
0.07 
-0.27 
366 
7 
3 
1 
0 
0 
1 
0 
Supplementary Table 2. Comparison of the 5nt inner loops naturally occurring in HA segment of H1N1 
strains with the mutants evaluated in EMPIRIC. ND implies that the loop sequence is absent/non-
synonymous in the EMPIRIC scan. 
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Model ANOVA 
P-value 
R2 
s ~HAexpr 
s~HAvir 
s~vRNAratio 
s~'GmRNA 
s~'GvRNA 
 
s~HAexpr + HAvirus 
s~HAexpr + 'GmRNA 
s~HAexpr + 'GvRNA 
s~HAexpr + vRNAratio 
 
s~HAexpr + HAvirus + 'GmRNA 
s~HAexpr + HAvirus + 'GvRNA 
s~HAexpr + HAvirus + vRNAratio 
 
 
 
 
 
 
0.014 
0.104 
0.890 
0.574 
 
0.053 
0.700 
0.787 
0.528 
0.136 
0.014 
0.061 
0.017 
 
0.680 
0.602 
0.529 
0.537 
 
0.752 
0.683 
0.681 
Supplementary Table 3. Two-way ANOVA comparison of multiple regression models linking fitness 
effects s to possible explanatory variables: HA protein abundance in viral particles (HAvir), HA expression 
in mammalian cells (HAexpr), vRNA HA/NA ratio (vRNAratio), and folding free energies 'G of 
nucleotides -4 to 37 relative to start codon, of HA vRNA and mRNA ('GvRNA and 'GmRNA, 
respectively). Among the linear regression models with a single explanatory variable, HA expression in 
mammalian cells was the best predictor of fitness (R2=0.528). ANOVA P-values for nested, pairwise 
comparisons of models with two or three explanatory variables are shown, comparing the best model 
using n explanatory variables to all models including n-1 variables, n=2,3. Best models are highlighted in 
bold. 
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Chapter III: Modulating influenza neuraminidase function influences the fitness landscape 
of hemagglutinin 
 
This manuscript is currently under preparation for submission as 
 
Aneth S. Canale, Troy W. Whitfield, Daniel R. Caffrey, Wayne A. Marasco, Celia A. Schiffer, 
Timothy F. Kowalik, Jeffrey D. Jensen, Robert W. Finberg, Konstantin B. Zeldovich, Jennifer P. 
Wang#, and Daniel N. A. Bolon#. “Modulating influenza neuraminidase function influences the 
fitness landscape of hemagglutinin”. 
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Abstract 
Influenza A virus is an important pathogen that causes hundreds of thousands of infections 
annually and continues to pose a great threat to global public health. The interaction of influenza 
A virus with the host receptors is mediated by the viral proteins hemagglutinin (HA) and 
neuraminidase (NA). HA recognizes and binds to sialic acid to initiate infection. NA recognizes 
and cleaves sialic acid interactions to prevent virus aggregation at the cell surface and release 
newly synthesized virus. Since HA and NA interact with the same molecule on the host cell 
surface but have opposing effects, a balance in receptor binding and receptor destroying 
activities of HA and NA is critical for efficient virus replication. This functional balance has 
been implicated in cross-species transmission of IAV, yet the molecular mechanism remains 
unclear. In the present study, we used the Extremely Methodological and Parallel Investigation 
of Randomized Individual Codons (EMPIRIC) approach to systematically investigate how 
changes in NA activity influence the fitness landscape of HA. We observed that inhibiting NA 
function by mutation did not rescue mutant HA. However, using the inhibitor oseltamivir 
enabled the rescue of HA mutations that were deleterious under wild type levels of NA function. 
Identifying oseltamivir-responsive HA mutations highlights the role of the HA-NA functional 
balance in the development of resistance to NA inhibitors. 
  
! 75!
Introduction 
Influenza viruses are negative-sense, single-stranded RNA viruses that belong to the 
Orthomyxoviridae family. This family of viruses is composed of three main genera, influenza A, 
influenza B, and influenza C [9]. Most human influenza infections are caused by influenza A 
virus (IAV) [26]. IAV has two main surface glycoproteins – hemagglutinin (HA) and 
neuraminidase (NA) that have counteracting roles in the virus cycle [18, 19]. During infection, 
HA of human IAV preferentially recognizes and binds to alpha 2,6-linked sialic acid on host cell 
glycans, while avian IAV preferentially binds to alpha 2,3-linked sialic acid [173]. Following the 
replication of the viral genomic RNA and packaging of newly synthesized viral proteins, NA 
cleaves sialic acid interactions to release nascent virus. The differences in recognition and 
binding patterns between HA and sialic acid on host receptors and the corresponding receptor 
cleavage by NA form the basis of host-specificity in IAV infections. Because HA and NA 
recognize the same molecule but have opposing functions, balanced receptor-binding strength by 
HA and receptor-destroying activity by NA is essential for optimal viral replication (Fig. 3.1a). 
Eighteen HA and 11 NA subtypes have been identified to date [13, 26]. Without any constraints, 
198 HA-NA combinations are expected to circulate in natural influenza. However, only a 
fraction of these subtypes has been isolated thus far. Reassortment studies conducted in the 
laboratory help to explain this observation [174, 175]. These studies showed that not all HA-NA 
combinations result in viable viruses. Kaverin et al. showed that combining a human H1N1 
variant with different mammalian and avian viruses resulted in viruses with a wide array of 
infectivity. For instance, reassortants with avian HAs (H3, H4, H10, and H13) paired with 
human NA resulted in viruses that replicated poorly in embryonated chicken eggs, suggesting 
mismatch in HA and NA function [176]. These observations indicate that a balance in the levels 
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of HA and NA function is essential for viral infectivity, and is the determining factor in the 
emergence of new HA and NA combinations in circulating viruses. However, the functional 
constraints underlying genomic reassortment in IAV are poorly understood. 
Other studies have shown that matching levels of receptor binding and receptor 
destroying activities of HA and NA are critical for productive infection by IAV. By manipulating 
NA properties, studies have shown that truncating the length of the NA stalk results in reduced 
NA function ultimately leading to viral attenuation in embryonated eggs [63, 177]. However, 
attenuated viruses appeared to be rescued by two mechanisms: the first was by insertions in NA 
that restored NA stalk length, and the second was by accumulating mutations in HA [63, 178]. 
Mapping HA mutations with rescue potential to structure showed that these mutations were 
mostly located near the receptor binding site, suggesting that reduced receptor binding 
established a new HA-NA functional balance. In another study, altering HA receptor binding 
strength by manipulating the N-linked glycans near the receptor site also resulted in attenuated 
viruses [179, 180]. In this study, optimal viral replication was only observed when truncated NA 
was matched with weak binding HA, or when full length NA was matched with stronger receptor 
binding. While complementary levels of HA and NA function allowed virus rescue, the limits of 
functional rescue under selection pressure remain understudied.  
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Figure 3.1. Using the EMPIRIC approach to study the role of HA-NA functional balance in IAV 
replication. A) Illustration of the match in receptor binding strength by HA and receptor cleavage by NA 
that is essential for optimal viral replication. B) Mapping the region covered in the current study (aa 192-
210 and 222-231 in magenta) onto the HA structure (PDB 1HGG). Sialic acid is shown in yellow. C) 
Sequence conservation of the region under study over different HA subtypes. Consensus sequences were 
generated from 1243 pandemic H1, 1315 non-pandemic H1, 598 H2, 1506 H3, 1585 H5, 1770 H7, 1168 
H9 and 925 H10 sequences retrieved from the Influenza Research Database D) Illustration of the 
experimental approach utilized to systematically study HA-NA functional balance.  
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Oseltamivir is a competitive NA inhibitor that inhibits the budding of progeny virus, and 
is widely used to treat influenza infections [181, 182]. However, oseltamivir-resistant viruses 
emerged in 2007 to 2008 and continue to undermined the reliability of oseltamivir in the 
treatment of influenza infections [48, 183]. Characterization of oseltamivir-resistant viruses 
revealed a high prevalence of the H275Y mutation (N1 numbering system) in NA [184, 185]. 
This mutation is located near the active site of NA and confers resistance by reducing oseltamivir 
binding affinity [186, 187]. HA mutations that confer resistance to NA inhibitors both in the 
presence and absence of the H275Y mutation have been identified [66, 188, 189]. These 
mutations exhibited reduced receptor binding strength, yet their role in the IAV evolutionary 
trajectory is not fully appreciated. Understanding the HA-NA functional balance will help define 
the evolutionary constraints shaping IAV evolution and provide better understanding of 
interspecies transmission and the development of drug resistance. 
Taken together, these studies provide substantial evidence that the HA-NA functional 
balance is critical for productive infection by IAV and for viral adaptation to new environment. 
However, the degree to which IAV can tolerate a functional imbalance between receptor binding 
and receptor destroying while remaining infectious, and the molecular mechanism guiding the 
reinstatement of this functional balance are not well understood. Understanding the molecular 
factors governing the HA-NA functional balance under different environmental conditions will 
define what drives influenza evolution, potentially identify additional anti-influenza therapeutic 
targets, and help minimize the emergence of drug resistance.  
 In the present study, we adapted the Exceedingly Meticulous and Parallel Investigation of 
Randomized Individual Codons (EMPIRIC) approach that utilizes high-throughput mutational 
scanning in combination with bulk competition assays [90, 100, 118] to systematically 
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investigate how different NA perturbations affect the fitness landscape of HA. We modulated 
NA activity by mutation, by adding the NA inhibitor oseltamivir, and also used a combined 
mutation and drug pressure approach. We observed that inhibiting NA function by mutation 
alone was not enough to rescue HA mutations with reduced receptor binding strength. However, 
inhibition by oseltamivir alone or by NA mutation in combination with oseltamivir supported the 
rescue of HA mutations. Our results suggest that a threshold in NA function must be surpassed 
for the HA-NA tradeoff and rescue in virus function to occur.  
 
Results 
Measuring fitness effects of mutations in the HA receptor binding site 
We studied the effects of all possible single-nucleotide mutations in two 10-amino acid 
regions covering the receptor binding site of HA (Fig. 3.1b). We chose the regions to include the 
highly conserved histidine, histidine and proline residues at positions 196-199 described to 
directly interact with the host receptor (Fig. 3.1c). Viruses that were recovered using a previously 
described approach [100] were used to infect MDCK cells and next-gen deep sequencing was 
used to measure mutant frequency in the viral pool before and after bulk competition (Fig. 1d). 
Experimental fitness effects were calculated relative to wild type (s = 0) and stop codons (s = -1). 
Fitness measurements were reproducible between bulk competition replicates (R2 = 0.89, Fig. 
3.2a). Stop codons were consistently depleted during the competition and wild type synonyms 
clustered around wild type-like fitness (Fig. 3.2b). Many mutations introduced in this region 
caused a fitness defect under wild type NA (Fig. 3.2c). This observation is consistent with the 
importance of this region in binding to host receptors to initiate infection.  
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Figure 3.2. Mutations at the HA receptor binding site impact virus fitness. A) The EMPIRIC approach 
provides a reproducible approach to measure experimental fitness effects (R2 = 0.89). Synonymous 
substitutions are shown as open dots, non-synonymous substitutions as black dots, and stop codons as 
open squares. B) Fitness effects of wild type synonyms cluster near wild type-like fitness (s = 0), while 
stop codons cluster near s = -1. C) Distribution of fitness effects (DFE) of mutations at positions 192-201 
and 222-231.   
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Fitness effects of HA mutations in the presence of the NA inhibitor oseltamivir  
Oseltamivir is a NA inhibitor that binds to the NA active site and reduces enzyme activity 
thus inhibiting the release of progeny of virus. Oseltamivir remains the most common targeted 
therapy against influenza infections, despite the described resistance. Even with the widespread 
use, the effect of oseltamivir on the HA-NA functional balance remains poorly understood. To 
systematically investigate the effects of oseltamivir on HA mutations, we measured the 
experimental fitness effects of HA mutations in the presence of drug pressure from the NA 
inhibitor oseltamivir (Fig. 3.1d). 
We observed that even though oseltamivir does not bind directly with HA, this drug 
greatly influenced the fitness landscape of HA. Inhibiting NA function by oseltamivir allowed 
the identification of mutants that appeared to grow better than wild type virus (s > 0) under drug 
pressure (Fig. 3.3a). Fig. 3.3b shows the effects of oseltamivir on the distribution of fitness 
effects. Mutations that exhibited adaptive potential in the presence of oseltamivir had a wide 
distribution of fitness effects in the absence of drug pressure, ranging from wild type-like to 
highly deleterious (Fig. 3.3c). 
Mapping mutations with the highest adaptive potential in the presence of oseltamivir to 
structure shows that the most adaptive mutations cluster at an unstructured loop at the neck of the 
receptor binding pocket (Fig. 3.3d).  
 
van der Waals contacts between sialic acid and HA at the receptor binding site 
In order to investigate the role of molecular interactions at the receptor binding site in the 
observed fitness effects, MD simulations were performed on a A/WSN/33 HA model bound to 
sialic acid. Mapping average vdW energy to structure showed that the strongest interactions were 
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with residues at the bottom of the receptor binding pocket (W166 at -5.6 kcal/mol; T149 at -5.4 
kcal/mol) (Fig. 3.4a&b). Residues that bond the tightest to sialic acid were highly conserved 
between different HA subtypes (Fig. 3.4c). Of the 20-amino acid region randomized in this 
study, residues 196 – 200 were shown to interact with sialic acid (Fig. 3.4a). Mutations at these 
positions were generally deleterious under wild type levels but showed improved fitness and 
even adaptive potential under altered NA activity (Supplementary Fig. 3.1). This observation 
suggests that mutations that alter the optimized receptor binding strength were rescued under 
reduced levels of NA function. 
 
Experimental fitness effects correspond with patterns in sequenced isolates 
For these experiments, we used the 8-plasmid system to recover and study the H1N1 strain 
A/WSN/33. Due to differences in the environmental conditions and evolutionary constraints in 
natural infections compared to experimental conditions, we analyzed the relevance of our 
experimental results relative to natural evolution of IAV HA. We compared our experimental 
fitness measurements to the amino acid frequency of each mutation in a panel of 4452 non-
redundant sequences extracted from the Influenza Research Database (see Methods). We 
observed a significant correlation between experimental fitness estimates and mutant frequency 
in sequences of circulating variants (Fig. 3.5a, P = 0.02). Mutations that were highly abundant in 
circulating strains had wild type-like fitness in our bulk competition assay, whereas mutations 
that had fitness defects in our assay were rarely observed in circulating viruses. Observed 
differences maybe be due to sequence differences between our model A/WSN/33 strain and 
circulating viruses (Fig. 3.1c), as well as other factors such as epistasis between HA residues 
outside the region covered in the current study. 
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Figure 3.3. Modulating NA function using the inhibitor oseltamivir influences the fitness landscape of 
HA mutations. A) Scatter plot showing experimental fitness effects of HA mutations under wild type 
levels of NA function (light blue) and under inhibition by 1 µM oseltamivir. B) Oseltamivir alters the 
DFE of HA mutations and enables the rescue of mutant virus. C) Correlation between mutant fitness in 
the presence and absence of drug pressure. Oseltamivir responsive mutations deviate from the diagonal. 
D) Mapping HA mutations with the highest rescue potential to structure (PDB 1HGG). These mutations 
cluster on an unstructured loop region at the neck of the receptor binding pocket. 
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Figure 3.4. Using MD simulations to study van der Waals contacts between sialic acid on host receptor 
and HA residues at the receptor binding site. A) HA residues that interact with sialic acid (cut-off 0.05 
kcal/mol). B) Mapping van der Waals energies to the model structure of A/WSN/33 HA. Red shows 
strongest interactions while blue shows weak interactions. Strongest interactions were observed at the 
bottom of the receptor binding pocket while the neck of the binding pocket, which is less structured, had 
weak interactions. C) Sequence conservation of HA residues that exhibited the strongest van der Waals 
interactions with sialic acid. Sequence logo was created from 2355 H1 sequences deposited from 2007 to 
2009.  
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 Measuring the fitness of HA mutants under selection pressure by oseltamivir showed that 
oseltamivir influences the fitness landscape of HA. In order to investigate the relevance of the 
effects of oseltamivir observed in our bulk competition study we analyzed 2355 H1 sequences 
retrieved from the Influenza Research Database from the years 2007 – 2009 when oseltamivir 
was widely used to treat influenza infections. We observed a switch in amino acid preference at 
positions 195, 199, 200, and 201 near the receptor binding sites, as well as at positions 223, 224, 
and 225 distal from the binding site (Fig. 3.5b&c) and that may coincide with the onset of 
widespread use of oseltamivir. Our experimental fitness measurements also show that lysines at 
positions 224 and 225 were deleterious under wild type levels of NA activity but became 
beneficial in the presence of oseltamivir. 
 
Biochemical properties of amino acids partly explain observed fitness effects 
 We used the BLOSUM62 substitution matrix to investigate the role of amino acid 
similarity in the observed fitness effects (Supplementary Fig. 3.2a). Amino acid properties 
explained about 15% of the observed fitness effects under wild type NA (P = 0.007). 
Substitution to a biochemically similar amino acid generally resulted in minimal fitness defects, 
while substitution to a dissimilar amino acid resulted in a wide distribution of fitness effects. 
However, in the presence of selection pressure by oseltamivir, this pattern disappears 
(Supplementary Fig. 3.2b). This suggests that other factors, such as binding interactions and the 
local environment, may also influence fitness under stress conditions. 
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Figure 3.5. Experimental fitness effects measured in bulk competition correspond with patterns seen in 
circulating viruses. A) A significant correlation exists between experimental fitness measurements and 
mutant frequency observed in sequenced circulating isolates (P = 0.02). B) Comparing HA sequences 
before the widespread use of oseltamivir and sequences isolated in 2007-2009. Sequence variations are 
observed at positions 195, 199, 200, 201, 224, 225, and 227. C) Mapping regions with sequence variation 
to structure (PDB 1HGG). Some of these mutations cluster on the unstructured region of the receptor 
binding pocket, while residues 224, 225, and 227 are distal from the receptor binding pocket and do not 
interact with sialic acid. 
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Analyzing positional tolerance to mutation 
We studied the effects of all possible single nucleotide mutations for a 20-amino acid 
region at the receptor binding pocket of HA. Calculating the average fitness effect of all 
mutations at each position revealed the sensitivity of each position to mutations (Supplementary 
Fig. 3.2c). We observed that most positions in this region were sensitive to substitutions. 
However, most positions had improved fitness in the presence of oseltamivir with positions 200 
and 228 showing the greatest fitness advantage under drug pressure. Residues 194, 195, 196, 226 
and 231 showed minimal response to oseltamivir. Analysis of sequenced isolates showed that 
residues 194, 195, and 196 are highly conserved in all HA subtypes (Fig. 3.1c) and have been 
shown to interact with sialic acid [190]. Positions 226 and 231 appear to only be conserved in H1 
HA and have not been implicated in receptor binding (Fig. 3.1c).  
 
Modulating NA function by mutation influences the HA fitness landscape 
 Previous studies have shown that a functional balance in receptor binding strength by HA 
and receptor cleavage by NA is important for productive infectivity by IAV [179, 191]. 
However, a systematic and comprehensive investigation of this functional balance has not yet 
been performed. In order to study the molecular mechanism of the HA-NA functional balance, 
we measured the experimental fitness effects of HA mutations under different levels of NA 
function (Fig. 3.6a). We studied effects of modulating NA activity by introducing one of the 
following mutations: I223M, H275Y, Y276F or N295S (Fig. 3.6b). We chose these mutations 
because of their relevance in oseltamivir resistance in circulating viruses [192, 193]. 
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 Perturbing NA activity by mutation had minimal effect on the fitness landscape of HA 
(Fig. 3.6c). We observed that the distribution of fitness effects had a bimodal distribution with a 
big peak near the fitness effect of the NA mutation and another peak at null fitness. Inhibiting 
NA function by mutation failed to identify HA mutations with adaptive potential, as seen in the 
presence of oseltamivir (Fig. 3.6c, d, e, f). Although present, beneficial mutations under mutant 
NA background have modest fitness benefits. Interestingly, there were no overlap between 
adaptive mutations in oseltamivir and adaptive mutations under mutant NA (Supplementary Figs.  
3.3 & 3.4). This trend suggests that there may be two different mechanisms to adaptation when 
modulating NA function by drug compared to modulation by mutation. However, comparing HA 
fitness under different NA mutations showed some correlation (Supplementary Fig. 3.5), 
indicating that these mutations may have similar effects on the fitness landscape of HA. 
 
Combined effects of mutation and drug pressure on NA has rescue potential 
 We analyzed the effects of different NA perturbations on the HA fitness landscape. Our 
results show that the means of modulating NA function does influence the resulting fitness 
landscape. The mutations we have used in our study impact virus growth by 25-30%. We used 
oseltamivir concentrations that inhibit virus growth by 50% under wild type conditions. As such, 
we were interested in studying the combined effects of these pressures on virus function (Fig. 
3.6a). We previously observed that NA mutations alone had limited potential to identify adaptive 
HA mutations (Fig. 3.6c, d, e, f). However, under the influence of both mutation and drug 
pressure, we identified more mutations with even greater adaptive potential than in either 
condition alone (Fig. 3.7a). Analyzing the correlation between different NA backgrounds in the 
presence of oseltamivir revealed common adaptive mutations (Fig. 3.7b). For the NA mutations  
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Figure 3.6. Modulating NA function by mutation shifts the DFE towards deleterious effects. A) 
Modifying the EMPIRIC approach to study effects of NA mutations on the fitness landscape of HA. B) 
Fitness effects of the NA mutations used in the study in the presence and absence of oseltamivir [100]. C-
F) DFE of HA mutations under mutant NA backgrounds. 
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H275Y and N295S, oseltamivir appears to rescue mutations with wild type-like fitness, whereas 
under I223M and Y276F oseltamivir appears to mostly rescue deleterious mutations 
(Supplementary Fig. 3.6). 
 
Positional sensitivity to oseltamivir under varying levels of NA function 
In order to further investigate HA sensitivity to oseltamivir we compared the average 
fitness of all HA mutations for each position across different levels of NA function conferred by 
either mutation or by the combined effect of mutation and oseltamivir. We observed that under 
mutant NA, the oseltamivir insensitivity at the receptor binding site largely disappears 
(Supplementary Fig 3.7). This may indicate that inhibiting NA activity by both mutation and 
drug pressure may eliminate the need for the previously optimized strong binding to the receptor.  
 
Validating bulk fitness measurements by studying individual clones in isolation  
In order to validate experimental fitness effects measured in bulk competition, we 
measured the fitness of a panel of 22 individually cloned HA mutants (Table 3.1). For further 
analysis in isolation we chose mutations that were deleterious under wild type levels of NA 
function but were generally beneficial at non-wild type NA levels. Under unmodified levels of 
NA function, all of the mutants analyzed had smaller plaques compared to wild type (average 
radius = 123.66 ±Z5.915 µm), except for the mutant N223I (Fig. 3.8a & b) (average radius = 
129.37 ±Z4.14 µm). In the presence of oseltamivir, all viruses had much smaller plaques (average 
radius = 16.3 µm), including the wild type (average radius = 11.48 ±Z2.58 µm). Interestingly, in  
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Figure 3.7. Combined effects of NA mutations and oseltamivir result in the rescue of HA mutants. A) 
Summary of the experimental fitness effects of HA mutants under wild type and mutant NA both in the 
absence (light hues) and presence (dark hues) of oseltamivir pressure. B-E) DFE of HA mutations under 
the combined pressure of NA mutations and oseltamivir.  
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the presence of oseltamivir, viruses carrying the N295S NA mutation had plaques that were more 
than double the size of wild type viruses under oseltamivir (average radius = 24.17 ± 3.2 µm) 
(Fig. 3.8c). We observed high reproducibility between our fitness measurements in bulk 
competition and mutant fitness measured in isolation (R2 = 0.82 Fig 3.8d). Fitness effects were 
dependent on the environmental condition tested (see Fig 3.8e).  
 
Rescued HA mutations exhibit reduced receptor binding 
 Functional balance in the receptor binding strength of HA and the sialidase activity of 
NA are important for the initiation and propagation of infection by IAV. Mutations that offset 
this balance have been shown to confer a fitness defect [63, 66]. However, previous studies have 
shown that over time new mutations in the virus will lead to the reinstatement of the HA-NA 
functional balance. As such, we speculate that inhibiting wild type NA function by using 
oseltamivir allows the identification and rescue of HA mutations with reduced receptor binding 
strength to match the reduced levels of NA function. 
 We used the hemagglutination assay to measure receptor binding normalized to virus titer 
for 5 mutations H197N, H197Y, S200N, N223Y and P228A under wild type and mutant NA 
(Fig 3.9a). We calculated receptor binding potential as the ratio between virus titer (pfu/ml) and 
hemagglutination units (HAU). Weak binding corresponds with a high pfu/HAU ratio, and vice 
versa. All mutations exhibited reduced receptor binding strength relative to wild type virus, 
except for the H197N mutation. There was no clear trend between receptor binding strength, 
calculated as pfu/HAU, and experimental fitness (Fig 3.9b, p value > 0.05). We compared 
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Figure 3.8. Validation of bulk fitness measurements by studies on individual IAV clones. A) Plaque size 
measurements of individual mutants in isolation. In blue are plaque size of HA mutants under wild type 
NA in the absence (light blue) and presence (dark blue) of oseltamivir. Plaque sizes were also measured 
under I223M, H275Y and N295S NA mutations. The panel of mutations carrying the N295S mutation 
was studied in the absence and presence of oseltamivir. B) Distribution of plaque sizes based on NA 
background. Color legend as in panel A. C) Images of plaques of wild type virus in the absence and 
presence of oseltamivir, and for the S200N mutation under N295S mutation in the presence and absence 
of oseltamivir. D) Results show high reproducibility between experimental fitness effects in bulk 
competition and plaque size normalized to wild type. Plaque size measurements in the absence of 
oseltamivir are shown as black dots and measurements in the presence of oseltamivir as shown as open 
dots. E) Plaque size measurements in the presence (open dots) and absence (black dots) of drug pressure. 
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receptor binding strength and NA activity previously measured by the enzymatic MUNANA 
assay (Fig 3.9c). Our results are inconclusive due to the number of data points available, but the 
trend suggests that HA mutations under wild type NA shift the HA-NA functional balance away 
from wild type, thus conferring a fitness defect. However, under the N295S NA mutation we see 
a modest increase in virus fitness at new levels of HA-NA ratios (Fig 3.9d). Further studies will 
help elucidate the functional constraints governing the observed balance in HA-NA function and 
the functional constraints governing this pattern of rescue. 
 
Mutant plaque size corresponds with rescue potential 
 We speculated that when NA function is perturbed, the tradeoff in HA-NA function is 
condition-specific and only comes into play when a certain threshold in NA function is crossed. 
In order to test this hypothesis, we analyzed the number of adaptive HA mutations under each 
NA condition (Fig 3.10). Inhibiting NA function by mutation alone may not have reached the 
functional threshold to trigger the rescue of HA mutations. Inhibiting NA function by oseltamivir 
and by combining oseltamivir with mutation surpassed the threshold and enabled the rescue of 
HA mutations. 
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Figure 3.9. Mutations near the receptor binding site influence receptor binding. A) Receptor binding 
potential represented by the ratio between viral titer and hemagglutination units. HA mutations were 
analyzed under wild type and N295 NA backgrounds. B) The correlation between fitness measured in 
bulk competition and receptor binding potential was not significant (p value > 0.05). C) Previously 
quantified enzyme activity of NA mutations used in this study [100]. D) Relationship between mutant 
fitness measured in bulk competition and HA-NA activity represented by the ratio between receptor 
binding potential and NA enzyme activity measured by MUNANA.  
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Figure 3.10. Relationship between NA activity and the rescue of HA mutations. A and B) Number of 
adaptive HA mutations correspond with the absolute effect of NA activity on virus function.   
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Discussion 
We adapted the EMPIRIC approach to systematically investigate the functional balance 
between receptor binding by HA and receptor cleavage by NA. Results from bulk competition 
assays show that most mutations at the HA receptor binding site impact virus fitness. This 
observation agrees with previous findings that disturbing the HA-NA functional balance leads to 
reduced virus replication [179, 194, 195]. We validated the observed fitness effects by studying 
the fitness of a panel of individually cloned mutations in isolation. Mutant fitness effects were 
highly reproducible between bulk competition measurements and in studies on individual 
mutants in isolation. Experimental fitness effects measured by bulk competition were consistent 
with patterns of mutant frequency observed in sequenced circulating variants, suggesting that the 
EMPIRIC approach captures the constraints present in nature. 
Previous studies have shown that compatible levels of HA and NA function are important 
for virus function. We speculated that modulating NA activity, either by using NA inhibitors or 
by introducing mutations, will lead to the rescue of HA mutants with reduced function. To test 
this hypothesis, we investigated how changes in the level of NA activity affect the fitness 
landscape of HA. In the presence of oseltamivir, we observed the rescue of HA mutations that 
had reduced fitness at wild type levels of NA function, indicating that HA-NA functional balance 
is more important than HA and NA activity levels for virus function [176, 195]. We identified 
oseltamivir-responsive HA mutations that may be involved in maintaining the HA-NA functional 
balance. These mutations appear to compensate for the reduced NA function thus allowing virus 
growth in the presence of oseltamivir. Some of these variants were observed in HA following the 
introduction of oseltamivir in 2007.  
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Investigating the rescue potential of mutant NA revealed that inhibiting NA function by 
mutation had minimal potential to rescue HA mutations under standard conditions. This 
observation indicates that the means of modulating NA activity does affect the resulting fitness 
landscape of HA. However, examining the combined effects of inhibiting NA function by 
mutation and by oseltamivir revealed greater rescue potential when compared to inhibition by 
oseltamivir alone. The improved fitness of the NA mutations used in this study in the presence of 
oseltamivir may have contributed to the increased rescue potential seen under drug pressure, but 
the mechanism is unclear.  
In order to examine the limitations in HA rescue, we analyzed the relationship between 
the level of NA function and the number of HA mutations rescued. There was a sigmoidal non-
linear relationship between NA activity, measured by mutant plaque size, and the potential to 
rescue HA mutations. This relationship suggests that reducing NA activity will only rescue HA 
mutations once a certain threshold level of NA activity is surpassed, after which the rescue 
potential plateaus. Further studies will be needed to further characterize this rescue pattern and to 
explain the role of this rescue pattern in cross-species transmission and infectivity.  
HA-NA functional balance is often altered by genetic drift, antiviral agents that inhibit 
NA function, and during adaptation to a new host following cross-species transmission of IAV 
[60, 196]. Due to the high mutation rate inherent in IAV, the virus establishes a new balance that 
allows continued virus replication. Understanding the functional constraints shaping the re-
establishment of the HA-NA functional balance can help inform the control of cross-species 
transmission of IAV, help to combat the ongoing problem of resistance to oseltamivir inhibitors, 
and help inform the design of more effective therapeutic agents.  
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Materials and methods 
Engineering plasmid libraries 
Single nucleotide mutant libraries were generated, as previously described, for a 20-amino acid 
region (aa 192-202 and 222-231) surrounding the receptor binding site of HA [90]. Briefly, 
nucleotides encoding amino acid 1 to 1650 of IAV strain WSN/33 HA were transferred to the 
pRNDM plasmid and mutations were introduced using a cassette ligation strategy. We included 
additional stop codons at an elevated abundance as an internal control for each 10-amino acid 
window to allow detection even in the presence of potentially strong selection. Mutant libraries 
were transferred to the pHW2000 plasmid using an engineered destination vector and Gibson 
Assembly (New England Biolabs) as described [100]. 
 
Virus recovery and quantification 
The pHW2000-based 8-plasmid system developed by the Webster group was used to 
recover viruses [15]. Briefly, MDCK and 293T cells were cultured and passaged as previously 
described [100]. Virus recovery was performed using 1 µg of HA plasmid library and 1 µg of 
each plasmid encoding the rest of the A/WSN/33 genome. These plasmids were transfected in a 
co-culture of MDCK and 293T cells using TransIT LT1 reagent (Mirus, Madison, WI). 
Transfection media was changed to serum-free media 6 h post-transfection. At 30 h post-
transfection TPCK  
trypsin (Sigma-Aldrich, St. Louis, MO) was added to the serum-free media to a final 
concentration of 0.5 µg/mL. Virus-containing supernatant was harvested at 72 h post-
transfection, centrifuged at 300g for 15 minutes, aliquoted and stored at -80ºC. Viruses were 
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recovered in two genetic conditions: with wild type NA or with either one NA mutation (I223M, 
H275Y, Y276F or N295S). 
Plaque assays were performed to quantify viral titer of the recovered virus as previously 
described [197]. Briefly, virus-containing supernatant was diluted in a 10-fold serial dilution and 
added to confluent MDCK cells. Virus was allowed to bind to MDCK cells for 1 h at 37ºC 
followed by washing off of unbound viruses with PBS. Infected cells were overlaid with 0.5% 
agar in DMEM and incubated at 37ºC for 48 h. Plaques were stained with antibody against IAV 
NP and visually counted. 
 
Growth competition experiments in cell culture 
Bulk competition experiments in culture were conducted as previously described [100]. Briefly, 
MDCK cells were plated in 6-well plates at 106 cells per well about 24 h before infection. Cells 
were washed with PBS right before infection, followed by cDMEM Dulbecco's modified Eagle's 
medium, 100 U/mL penicillin, 100 µg/mL streptomycin, and 7.5% bovine serum albumin. 
Viruses were diluted in influenza virus growth medium (cDMEM/ BSA with 1 µg/mL TPCK 
trypsin) and used to infect MDCK cells at a multiplicity of infection of 0.01, in triplicates, either 
in the presence or absence of 1 µM oseltamivir. Cells were incubated with virus for 1 h at 37ºC. 
Unbound virus was washed off with PBS. Infected cells were grown in influenza virus growth 
media in the presence or absence of oseltamivir at 37ºC. At 48 h post-infection, virus-containing 
supernatant was harvested, centrifuged at 300g for 15 minutes and stored at -80ºC. 
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Quantification of mutant frequency 
Mutant frequency following bulk competition was quantified as previously described [100]. 
Briefly, harvested supernatant was treated with DNase (New England BioLabs, Ipswich, MA) 
for 1 h at 37ºC in order to degrade plasmid DNA. Viral RNA was extracted using the QIAamp 
Viral RNA minikit (Qiagen, Germantown, MD) and eluted in 40µl of elution buffer. HA cDNA 
was generated using Superscript III (Life Technologies, Beverly, MA) and HA-specific RT 
primers. Sample processing for sequencing was performed by using PCR to introduce restriction 
sites, followed by digestion and ligation of sample-specific adapters. Adapter-ligated samples 
were quantified, pooled and sequenced on the Illumina single read 36-bp sequencing on a 
Genome Analyzer II. Reads with greater than 99.5% confidence were analyzed. The relative 
abundance of each mutant was calculated as log2(mutant/WT). Fitness effect in bulk competition 
was calculated as the difference in relative mutant frequency before and after competition.  
 
Validation of mutant fitness in clonal isolates 
A panel of 22 individual mutations were cloned and virus recovery was performed as described 
above. The titer for each recovered viral variant was determined by plaque assay with minor 
modifications. Briefly, virus was diluted either in the presence or absence of 1 µM oseltamivir 
and incubated for 1 h at 37ºC. In the drug-treated condition, 1 µM oseltamivir was also added in 
the agar overlay. Plaques were visualized after 48 h and images were acquired using a Nikon 
SMZ1500 microscope. The NIS Elements-BR Analysis program was used to measure the radius 
of about 10-15 plaques from the same quadrant in each well. The average plaque size for each 
mutant was calculated and used as an estimate of viral growth.  
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Using molecular dynamics simulations to study molecular interactions  
Molecular dynamics simulations were performed to calculate van der Waals contacts between 
sialic acid and HA at the receptor binding site. A homology model of A/WSN/33 HA was 
created using the SWISS-MODEL modelling server using the 1918 HA (PDB 1HGG) as the 
template. Heteromultimer assembly and ligand docking was performed using the Prime Structure 
Prediction panel on Schrodinger [198]. Molecular dynamics simulations were performed as 
previously described [199]. Briefly, the modeled structures were prepared for simulation using 
the octahedron solvent box. Desmond was used for all simulations using the OPLS2005 force 
field. All simulations were performed for 10 ns. 
 
Alignment of naturally occurring HA sequences 
We retrieved 4452 HA sequences from the Influenza Research Database (IRD) [146] containing 
only H1N1 strains and excluding overrepresented pandemic H1N1. These sequences were 
aligned and filtered to eliminate HA sequences with insertions and deletions near the 5’ end, 
resulting in 4374 HA sequences. The frequency of each codon at each position was calculated 
and compared to fitness data from our bulk competition experiment. 
 
Hemagglutination assays to measure receptor binding 
Human red blood cells were isolated by centrifuging serum at 875 rpm for 15 minutes. The 
supernatant was carefully removed and the pellet containing isolated red blood cells was washed 
three times with 10 ml PBS. A round-bottom 96-well plate was set up with duplicates of 2-fold 
serially diluted virus to a total of 50 µl. A negative control containing PBS only was also 
included. 50 µl of diluted red blood cells were added to each well and mixed carefully. Plates 
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were incubated at 4ºC for 45 minutes. Plates were visualized using a magnifying mirror. Wells 
with uniform red color were considered positive while wells with a red button at the center of the 
well were considered negative for hemagglutination. Resulting hemagglutination units were 
normalized to viral titer. 
 
Measuring NA activity in vitro 
Measurements of NA enzyme activity were previously performed in [100] using the fluorogenic 
2,-(4-methylumbelliferyl)-α-D-N-acetylneuraminic acid (MUNANA) substrate following 
instructions provided by the manufacturer (Life Technologies, Carlsbad, CA). Briefly, 
recombinant viruses were incubated with MUNANA substrate at a final concentration of 0.1 mM 
for 1 h at 37 °C with shaking. Fluorescence was then measured using a Victor X5 plate reader 
(PerkinElmer, Waltham, MA) with a 355 ± 10 nm excitation filter and a 460 ± 20 nm emission 
filter. Relative fluorescence was normalized to virus titer determined by plaque assay. 
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Variant 
H197N 
H197Y 
S199Y 
S200N 
N223I 
N223Y 
P228A 
H197NI223M 
H197YI223M 
S200NI223M 
N223YI223M 
P228AI223M 
H197NH275Y 
H197YH275Y 
S200NH275Y 
N223YH275Y 
P228AH275Y 
H197NN295S 
H197YN295S 
S200NN295S 
N223YN295S 
P228AN295S 
Table 3.1. Mutants analyzed as individually cloned variants. 
  
! 105!
                       
Supplementary Fig 3.1. Average experimental fitness effects of mutations at HA residues that interact 
with sialic acid that were covered in the present fitness scan. Mutations at these residues were deleterious 
under standard conditions (no drug) in wild type and in mutant NA backgrounds. In the presence of 
oseltamivir, mutations at these positions rescued virus function. 
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Supplementary Figure 3.2. Analyzing properties of HA mutations. A) Relationship between amino acid 
similarity and mutant fitness in bulk competition. B) Comparing amino acid similarity and mutant fitness 
under selection by oseltamivir. C) Analyzing positional sensitivity to mutation in the presence (purple 
dots) and absence (black dots) of drug pressure (wild type fitness = 0).  
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Supplementary Figure 3.3. Comparing the effects of inhibiting NA function by oseltamivir and by 
mutation A) I223M, B) H275Y, C) Y276F, and D) N295S.  
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Supplementary Figure 3.4. Comparing effects of inhibiting NA function by oseltamivir and by the 
combined effect of oseltamivir and mutation A) I223M, B) H275Y, C) Y276F, and D) N295S in NA. 
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Supplementary Figure 3.5. Comparing effects of different NA mutations on the fitness of HA mutations. 
A) Comparing the effects of I223M and H275Y. B) Comparing the effects of I223M and Y276F. C) 
Comparing the effects of I223M and N295S, D) Comparing the effects of H275Y and Y276F. E) 
Comparing the effects of H275Y and N295S. E) Comparing the effects of N295S and Y276F. 
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Supplementary Figure 3.6. Comparing the effects of oseltamivir under different NA backgrounds. A) 
I223M, B) H275Y, C) Y276F, and D) N295S. 
 
  
-1 0 1
-3
-2
-1
0
1
2
Fitness effect NAI223M
Fi
tn
es
s 
ef
fe
ct
 N
AI
22
3M
 +
 O
se
l
-1 0 1
-1
0
1
Fitness effect NAH275Y
Fi
tn
es
s 
ef
fe
ct
 N
AH
27
5Y
 +
 O
se
l
-1 0 1
-2
-1
0
1
2
3
Fitness effect NAY276F
Fi
tn
es
s 
ef
fe
ct
 N
AY
27
6F
 +
 O
se
l
-1 0 1
-4
-2
0
2
4
Fitness effect NAN295S
Fi
tn
es
s 
ef
fe
ct
 N
AN
29
5S
 +
 O
se
l
 
 
! 111!
         
Supplementary Figure 3.7. Analyzing positional sensitivity of HA to mutation under different levels of 
NA activity mediated by mutation alone or by mutation and inhibition by oseltamivir. A) I223M, B) 
H275Y, C) Y276F, and D) N295S – black dots show fitness under the respective mutant NA and purple 
dots show fitness under mutant NA in the presence of oseltamivir (wild type fitness = 0). E) Summarizing 
the effects of oseltamivir on HA fitness (sdrug - sno drug) under difference NA backgrounds.  
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Chapter IV: Discussion 
Overview 
IAV is a rapidly evolving virus that continues to threaten global public health, yet the 
functional constraints shaping the evolutionary trajectory of the virus are not fully understood. 
My dissertation research focused on adapting EMPIRIC, an approach that utilizes high 
throughput mutagenesis, bulk competition assays, and next-generation deep sequencing, to study 
the evolutionary constraints shaping IAV evolution and adaptation under different environmental 
conditions. In chapter II, I used EMPIRIC to study the effects of all possible single nucleotide 
mutations in the signal sequence of the IAV HA protein. We observed that both synonymous and 
non-synonymous substitutions in this region impacted viral fitness. Comparing effects of 
mutations in the signal sequence to a region outside the signal sequence showed that 
synonymous mutations had larger effects in the signal sequence than in the control region. The 
signal sequence also appeared to tolerate non-synonymous substitutions better than the control 
region. Analyzing synonymous substitutions revealed that RNA structural elements in this 
region, that appear to be species-specific, may be important for virus function. Other factors, 
such as protein synthesis efficiency and protein abundance in viral particles, were also correlated 
with fitness. We observed evidence of stabilizing selection on HA abundance in virus particles. 
Both too much or too little HA appeared to negatively impact virus fitness. In chapter III, I used 
the EMPIRIC approach to investigate how changes in NA activity influence the HA-NA 
functional balance, and to investigate the effect of these changes on virus fitness. I used two 
different methods to modulate NA function – by mutation, and by using the NA inhibitor 
oseltamivir. Treatment with oseltamivir yielded much smaller plaques than viruses carrying 
mutant NA. This suggests that oseltamivir has larger effects on virus replication than the 
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analyzed NA mutations. In agreement with this observation, analyzing the effects of reduced NA 
activity revealed that inhibiting NA function by mutation had minimal effect on the fitness 
landscape of HA. We observed a shift in the distribution of fitness effects of mutations, but 
observed that inhibiting NA function by mutation failed to rescue HA mutations. However, 
inhibiting NA function either by oseltamivir alone or by mutation combined with oseltamivir led 
to the rescue of HA mutations. The combined effects of mutation and drug pressure by 
oseltamivir exhibited improved rescue potential. The plaques of the rescued mutations were up to 
three times as big as wild type plaques in the presence of oseltamivir. We observed a non-linear 
relationship between NA activity and the potential to rescue HA function in virus. These results 
suggest that the HA-NA tradeoff is observed when a certain threshold in NA function is crossed. 
In summary, we observed that majority mutations introduced in IAV HA conferred a fitness cost 
under standard conditions. Analyzing the patterns of mutational sensitivity combined with 
biochemical assays on a panel of individually cloned mutations began to explain the molecular 
mechanism underlying the observed fitness effects. Under drug pressure by oseltamivir, we 
identified HA residues that respond to changes in NA function leading to the rescue of virus 
replication. 
 
Synonymous substitutions exhibit greater fitness effects in the signal sequence  
Secretory proteins typically have a signal sequence that serves as a molecular address 
targeting these proteins to the ER for trafficking and secretion [130, 132, 200]. The first 14 to 16 
amino acids of the influenza A HA protein form the signal sequence. Previous studies have 
shown that large deletions in this region result in cytoplasmic accumulation of HA, suggesting 
the importance of the signal sequence in trafficking and surface expression [34, 140]. Analyzing 
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the amino acid sequences of the signal compared to the mature HA revealed higher sequence 
diversity in the signal sequence compared to the rest of HA. However, the evolutionary 
constraints shaping the evolution of the HA signal sequence remain unclear. 
 We used the EMPIRIC approach to study effects of mutations in the signal sequence of 
HA. Focusing on a small region of HA led to improved sensitivity and resolution of the fitness 
measurements. The improved resolution of this experimental setup allowed the measurement of 
the effects of both synonymous and non-synonymous substitutions on virus fitness. The observed 
fitness effects were also validated by studying individual mutations in isolation. When analyzed 
in isolation, synonymous mutations that exhibited deleterious effects in bulk competition also 
had smaller plaques compared to wild type. Effects of synonymous substitutions were further 
validated by studying their effects on the growth kinetics of viruses. Deleterious synonymous 
substitutions analyzed in isolation either exhibited a longer eclipse duration or reduced 
replication rate, leading to slower infection kinetics compared to wild type virus. 
 In order to quantify selection acting on the HA signal sequence relative to a neighboring 
region of HA, we compared the distributions of fitness effects of synonymous and non-
synonymous mutations. Synonymous substitutions had larger effects in the signal sequence than 
in the neighboring region used for comparison. Non-synonymous mutations were more tolerated 
in the signal than the neighboring region. Calculating the apparent ratio of selection between the 
two regions indicated that amino acid sequence of the signal may be evolving faster than that of 
the control region. This observation is consistent with the high sequence diversity observed in 
the signal peptides of sequenced circulating IAV variants. 
 Studying the molecular basis of the observed fitness effects revealed that majority of the 
synonymous mutations analyzed impacted protein synthesis efficiency in cell culture. This 
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observation was consistent with the previous observation that rare codons at the N-termini of 
proteins regulate translation [107, 124, 153]. However, analyzing protein abundance in released 
viruses showed apparent stabilizing selection on HA abundance per plaque forming unit. Further 
studies will be necessary to elucidate how changes in HA synthesis affect the ratio of infectious 
to non-infectious viruses per plaque forming unit, and to explain how this change shaped IAV 
evolution.  
 Results of the fitness effects of mutations in the HA signal sequence demonstrated that 
RNA structure may also be shaping the evolution of this region. Moss and colleagues studied the 
structural components of the IAV genome by performing RNA structure predictions based on 
suppression of synonymous codon usage and unusual thermodynamic stabilities [201]. The HA 
segment appeared to be less structured than the rest of the genome. However, this study 
combined IAV genome sequences from human, avian and swine hosts for their analyses, and 
may have missed species-specific structural components of the IAV genome. Our fitness scan 
using the EMPIRIC approach combined with analysis of sequenced circulating isolates from 
different hosts revealed species-specific differential preferences for a structured or unstructured 
loop at nucleotide positions 7 – 23. This region is part of a larger region that has been implicated 
in virus packaging [158, 161]. However, species-specific differences in IAV packaging are not 
fully understood. Studying the role of host factors in constraining this region will help our 
understanding of influenza function and cross-species transmission. 
 Overall, this study highlights that synonymous mutations are not evolutionarily neutral as 
proposed by previous theories. Synonymous mutations often impact fitness, thus necessitating 
the need to re-valuate the expression dN/dS that is widely used to measure the strength of natural 
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selection acting on protein-coding genes. As such, it is important to consider effects of 
synonymous mutations when calculating and predicting the evolution rate of different proteins. 
 
Adapting the EMPIRIC approach to study HA-NA functional balance 
 Many studies have shown the importance of the functional balance between receptor 
binding by HA and receptor cleavage by NA. Altogether, these studies show that productive viral 
infection is supported by matching levels of HA and NA activity. Viral evolution studies in the 
laboratory, as well sequence analysis of circulating viruses have shown that when this balance is 
perturbed, mutations in the virus that re-establish this balance will fix in the virus population [66, 
195]. However, the molecular mechanism, and the role of this balance in shaping IAV evolution 
remains unclear. 
 We adapted the EMPIRIC approach to investigate how changes in the level of receptor 
cleavage activity of NA influences the fitness landscape of HA mutations near the receptor 
binding site. We also sought to study whether the means of modulating NA function – by 
mutation or using the NA inhibitor oseltamivir - impacted the resulting fitness landscape. We 
observed that inhibiting NA function using oseltamivir had a larger effect than inhibition by 
mutation. Oseltamivir allowed the identification of HA mutations with adaptive potential in the 
presence of drug pressure. The fitness trends seen in our bulk competition results in the presence 
of oseltamivir were consistent with mutant frequencies observed in circulating viruses following 
the introduction of oseltamivir in the clinic.  
Our results show that there was a non-linear relationship between NA fitness effect, as 
measured by plaque size, and the potential to rescue HA mutations. Inhibiting NA function by 
mutation alone was not sufficient to rescue HA function, however it appears that oseltamivir 
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lowered NA function enough to establish a functional match with HA mutations. Previous 
studies have shown that IAV infection is initiated by many weak interactions between HA and 
sialic acid at the host cell receptor [202, 203]. However, the limitations in the range of HA 
binding strength to ensure successful virus binding and internalization remain unknown. 
Investigating the effect of HA and NA mutations on the HA-NA functional balance combined 
with phylogenetic analyses can elucidate the role of this balance on IAV evolutionary 
trajectories.  
The HA-NA functional balance has been implicated in the development of resistance 
against oseltamivir inhibitors [66]. In the current study, we use a systematic approach to identify 
HA mutations that respond to oseltamivir. Expanding this mutational scan to study the whole HA 
protein, and to study the effects of different drug pressures, such as zanamivir, will further 
explain the role of the HA-NA functional balance on the development of resistance against 
oseltamivir inhibitors. Understanding the molecular underpinnings of the HA-NA functional 
balance in IAV may help explain the functional balance between virus entry and exit in other 
viruses in the paramyxoviridae family, such as measles, sendai, and newcastle viruses. 
 
Using EMPIRIC to study protein function and evolution 
EMPIRIC is a high throughput mutational scanning approach that has been used widely 
to study sequence-structure-function relationships of proteins in the yeast system [90, 117-119], 
to study disease-causing genes in cell culture [204, 205], and to study viral proteins [100, 206]. 
This approach uncovers positional sensitivity of a protein to mutation, both under normal 
conditions and under different selective pressures. Combining results from EMPIRIC fitness 
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scans and structural and biochemical analyses began to explain the molecular mechanisms 
underlying protein function [119] and the development of drug resistance [170]. 
Compared to other mutational scanning approaches, EMPIRIC provides a high 
throughput approach that is also systematic and comprehensive. Cassette-based mutagenesis 
provides more control on the frequency and coverage of mutations in mutant plasmid libraries 
compared to error-prone PCR. Combining this method of library preparation and straightforward 
functional assays, EMPIRIC results in highly reproducible fitness measurements. However, due 
to current technological advances and reduced cost, plasmid library preparation in mutational 
scanning studies is shifting towards the use of parallel oligonucleotide synthesis [207]. This, and 
other similar approaches, will enable the production of high diversity barcoded libraries that will 
in turn increase throughput.  
Like all mutational scanning approaches, the EMPIRIC approach has shortcomings. The 
translation of EMPIRIC results to fitness effects of mutations in nature is dependent on the 
functional assay used. If the experimental conditions deviate from those of the natural function 
of the protein, then the fitness results obtained may be misleading. Additionally, the nature and 
strength of selective pressures that form part of the environmental condition under study must be 
in line with the pressures that will shape the evolution of a protein in nature. The EMPIRIC 
approach has additional limitations when used to study virus evolution. Bottlenecks such as 
during virus recovery from plasmid and during bulk competition assays can lead to inaccurate 
results. The presence of these bottlenecks often leads to limited throughput. Despite these 
drawbacks, the EMPIRIC approach provides a useful tool to study protein function and evolution 
under different environmental conditions.  
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On extrapolating EMPIRIC findings to circulating IAV 
 
Results from EMPIRIC studies on HA generally agree with patterns seen in sequences 
circulating viruses (P < 0.05). In these comparisons mutations with large fitness defects were 
present at a low frequency or were absent in sequences of circulating viruses. On the other hand, 
mutations that show minimal effects of virus fitness were abundant in circulating viruses. We 
acknowledge that the EMPIRIC approach provides information on the general trends of the 
fitness effects of mutations, and not the absolute fitness of each mutation. Studying effects of 
mutations in individual virus clones in isolation helps to validate fitness measurements from bulk 
competition experiments, indicating that this approach generally captures trends of virus 
evolution present in nature.  
 IAV is a rapidly evolving virus. As such, sequence differences between the laboratory 
strain A/WSN/33, that is commonly used for experimental evolution studies, and circulating 
strains may limit the dependability of results from mutational scanning studies. Ideally, 
performing IAV evolution experiments using viruses derived from the currently circulating 
viruses will provide the most accurate information on the evolutionary trajectory and potential 
for drug resistance in IAV. However, with the high rate of influenza virus evolution and failure 
to accurately predict predominant circulating variants has deemed this approach unfeasible. 
Nevertheless, information garnered from the current experimental setup provides insight into 
virus function and evolution. 
 
Future directions 
 
 In this dissertation project, I used the EMPIRIC approach to investigate the evolutionary 
constraints shaping IAV evolution. Specifically, I studied how mutations in the signal sequence 
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of IAV HA affects virus replication, and examined how the HA-NA functional balance 
influences virus function and evolution. 
 
Studying effects of signal sequence mutations on IAV replication 
 
 Studying effects of mutations in the signal sequence of HA showed that there is a 
complex relationship between viral factors, at the RNA and protein levels, and host factors that 
influence virus fitness. Future studies investigating host factors such as receptor specificity, 
tissue specificity, and antiviral responses may further explain the observed host-specific 
differences. Expanding these studies to the whole HA protein may reveal other host-specific 
structural constraints that as of yet remain unknown.  
 These studies also show that IAV may be under stabilizing selection for HA abundance in 
infectious particles, however, effects of changes in HA expression have not been explicitly 
investigated. Future studies analyzing the effects of changes in HA expression, by using different 
expression promoters for instance, in different IAV strains may explain virus function. 
Alternatively, similar studies investigating the effects of changes in NA abundance on virus 
function will be of interest. Since HA and NA are the main surface proteins of IAV, these studies 
may also elucidate virus antigenicity and host responses to IAV infection.  
 
Investigating HA-NA functional balance 
 
 The balance in HA and NA function is critical for virus replication, yet remains 
underexplored. Our results show that modulating NA function by oseltamivir enables the rescue 
of HA mutations, and that there is a non-linear relationship between NA activity and rescue 
potential. However, the molecular mechanism underlying this balance remains unknown. Future 
studies using modern strains such as A/Brisbane/59/2007 will show whether the observed rescue 
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pattern is a general phenomenon or whether the pattern is specific for the A/WSN/33 strain used 
for these studies. Additionally, using viruses with a different receptor specificity – a2,3-linked 
sialic acid instead of a2,6-linked sialic acid – may explain the role of this functional balance 
across different IAV host species.  
 
Conclusion 
 
IAV remains a public health threat largely because we do not fully understand its 
evolution. Learning the evolutionary constraints governing the function and evolution of IAV 
proteins is important for the efficient control of influenza infections. To date, the most effective 
way to control influenza infection is by vaccination. However, mismatch between IAV variants 
contained in the vaccine and circulating viruses continually undermines the effectiveness of the 
vaccine. Antiviral agents that inhibit NA function are the common place therapies used to treat 
influenza infections. Resistance to oseltamivir inhibitors that are widely used to treat influenza 
infections makes the control of IAV a challenge. In this dissertation, I used the EMPIRIC 
approach to study the evolutionary constraints shaping the evolution of the HA signal sequence. 
Results indicate that there is a complex interaction between viral, environmental, and host factors 
that facilitate virus function. I also used the EMPIRIC approach to study the role of the HA-NA 
functional balance in virus function, and in adaptation to drug pressure in the environment. This 
study highlighted the need to focus on both NA and HA in investigating resistance to oseltamivir 
inhibitors. Understanding the role of HA in drug resistance can inform the design of antiviral 
agents with reduced chance for resistance, and help identify new targets for IAV therapies. 
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Appendix - Mutations proximal to the signal peptidase cleavage site of influenza A virus 
hemagglutinin exhibit dominant negative properties 
 
This work was performed as a preliminary analysis to investigate the potential dominant negative 
properties of a list of HA mutations identified in a previous study. Follow-up experiments are 
required to elucidate the observed effects of HA mutations on the function of wild type protein. 
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Abstract  
Dominant negative mutations are mutations that disrupt protein function when co-expressed with 
wild type protein. Cold-adapted influenza A virus that exhibited dominant negative properties 
were identified in the early 1990s. Exploiting these dominant negative properties provided a new 
strategy for producing an attenuated live-virus vaccine for use in immunocompromised 
individuals, and provided an alternative approach for the design of antiviral agents. This 
approach showed promising results in ferrets that were co-infected with a virulent strain of 
influenza A virus. The development of these constructs for use in the clinic has not been a 
success. In this study, we identified mutations in the signal sequence of IAV HA that exhibited 
dominant negative properties. These mutations caused up to 300-fold reduction in virus titer in 
mixed transfections with wild type. Studying their effects on wild type HA expression revealed 
up to 50% reduced HA expression in mammalian cells. Dominant negative mutations in HA, the 
most antigenic influenza protein, can help inform vaccine development. 
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Introduction 
The N-terminus of the hemagglutinin protein of influenza A virus consists of a signal 
sequence that targets nascent HA to the endoplasmic reticulum (ER) for trafficking [135, 140]. 
Like many signal sequences, the HA signal sequence is composed of a positive charged amino 
terminal followed by a hydrophobic region and a polar region [130, 134]. Targeting of nascent 
HA to the ER is initiated by the signal recognition particle (SRP) binding to the hydrophobic 
region of the signal sequence which anchors at the SRP receptor on the ER membrane allowing 
insertion of the emerging protein into the translocon [132, 208]. A trypsin-like signal peptidase 
cleaves the signal peptide before HA exits the ER [134, 209]. HA trafficking mediated by the 
signal sequence has been shown to be critical for proper virus function as deletion mutations in 
the signal sequence show impaired function [140]. The amino acid sequence of the HA signal 
peptide is variable between different HA subtypes, yet the structural and biochemical properties 
are highly conserved. However, the role of the signal sequence in virus function and evolution 
remains understudied. 
Mutations with dominant negative properties have the ability to disrupt wild type protein 
function when overexpressed in a polypeptide [210]. Since dominant negative mutants result in 
attenuated wild type phenotype, they provide a useful tool to study protein function [211, 212] 
and have exhibited therapeutic potential [77, 213]. For instance, influenza A viruses carrying 
mutations in the matrix gene were shown to harbor dominant negative properties and present a 
potential novel class of antivirals against influenza [214]. Exploring the molecular properties of 
dominant negative IAV mutations for therapeutic purposes is of high importance especially with 
the increasing prevalence of resistance against the currently used drug oseltamivir. However, 
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identifying and characterizing IAV mutations with dominant negative properties for candidates 
as therapies, and how host factors respond to these properties remains underexplored. 
In the present study, we aim to identify signal sequence mutations that may have 
dominant negative effects on HA trafficking to the ER for surface expression. We used the 
dataset generated previously using the EMPIRIC (Exceedingly Meticulous and Parallel 
Investigation of Randomized Codons) approach to study effects of mutations in the signal 
sequence of IAV HA. We focused on mutations that were present in the plasmid library but were 
strongly depleted in the recovered virus population. In order to distinguish lethal from dominant 
negative mutations, we hypothesized that when studying these mutations in isolation only 
dominant negative mutations will disrupt wild type function. Furthermore, we speculated that 
wild type trafficking and surface expression will be greatly impacted by dominant negative 
mutations that inhibit signal peptide cleavage. We identified signal sequence mutations that 
caused up to 300-fold titer reduction in mixed transfections with wild type HA. These mutations 
also disrupted the surface expression and cellular localization of wild type HA.  
 
Results and discussion 
Mutations in the HA signal sequence disrupt wild type function 
The signal sequence is generally hydrophobic and has low molecular weight residues 
near the peptidase cut site [215] (Fig. 5.1a). While studying effects of mutations in the HA signal 
sequence, we observed that some mutations were abundant in the plasmid library but were highly 
depleted in recovered viruses (Fig. 5.1b). In order to study the dominant negative potential of 
these mutants, we performed mixed transfection assays with wild type plasmid and compared 
virus titer to true wild type. Mutations L6R, V7D, V7G and L8R had no impact on wild type titer  
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Figure 5.1. Mutations in the HA signal sequence can have dominant negative effects. A) Amino acid 
sequence of the A/WSN/33 HA signal sequence. The SRP binds at the hydrophobic region. The signal 
sequence is cleaved by host proteases and does not form part of the mature protein. B) Relative mutant 
abundance of highly depleted mutants in plasmid library and in recovered virus. C) Effects of a panel of 
individually cloned variants on wild type titer. D) Of the mutants in panel C, 5 variants were chosen for 
further analysis. 
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suggesting that these mutations may be lethal and not dominant negative. Mutations with the 
largest effect in mixed transfections were A11E, V13L, A17E, D18N and T19P (Fig. 5.1c). Our 
results show that T19P reduced wild type titer by about 300-fold. From this panel, we chose 
these 5 mutants for further analysis (Fig. 5.1d).  
 
Candidate mutations interfere with wild type HA expression in mammalian cells  
In order to study the effects of this panel of mutations on HA expression, we used a 
surface-display plasmid and co-expressed wild type and mutant plasmids in 293T cells (Fig. 
5.2a). When expressed alone, each of these mutations exhibited reduced surface expression, with 
the A11E mutant expressing about 25% of wild type HA levels. When co-expressed with wild 
type, all mutations appeared to disrupt wild type expression. V13L reduced wild type expression 
to about 50% (Fig. 5.2b). A17E and T19P mutations had the least effect on surface expression 
(Fig. 5.2b). Since these mutations had the largest effects on wild type titer but exhibited minimal 
effect on HA expression, we speculate that A17E and T19P mutations may impact the function 
of surface expressed protein. Further studies will help elucidate the molecular mechanism of the 
observed effects. However,  
We performed western blots to further investigate effects of mutations on HA expression. 
Consistent with our FACS results, all the mutants analyzed showed reduced HA expression (Fig. 
5.2c). A11E had the lowest levels of surface expression and appeared to affect the 
oligomerization of wild type HA. 
Previous studies have shown that the evolutionary trajectories of the IAV genome are 
significantly impacted by host proteostasis [216]. Although the molecular mechanism of the 
observed effects remains unknown, we speculated that abnormal signal sequence cleavage of  
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Figure 5.2. Candidate mutations disrupt HA expression in mammalian cells. A) Experimental approach to 
study effects of mutations on HA expression. B & C) Effects of HA mutants on wild type HA expression 
measured by flow cytometry (B) and by western blot (C). In (B) Blue bars show single-variant expression 
and magenta bars show co-expression of wild type and mutant variants. D) Analyzing effects of HA 
mutations on calreticulin expression. In C & D, a red star denotes mutant HA alone and a yellow star 
denotes co-transfected wild type and mutant HA. 
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these variants may trigger the protein folding stress response in mixed transfections. There were 
no changes in calreticulin expression in single and mixed transfections when compared to wild 
type (Fig. 5.2d). Studying other chaperones in the ER, specifically calnexin and BiP, may 
confirm whether or not these signal sequence mutations trigger the protein misfolding response.  
 
Using immunostaining to study cellular localization of mutant HA 
 We used immunostaining and fluorescence microscopy to analyze effects of candidate 
mutations on expression levels and cellular localization of wild type HA. Wild type HA was 
highly expressed, and was localized along the cell membrane (Fig. 5.3a). Mixed transfections of 
wild type and mutant HA showed reduced HA expression on the cell surface with A11E showing 
the least expression (Fig. 5.3b – f). The mutation D18N appeared to change cellular localization 
to a punctate distribution. Further studies using quantitative confocal microscopy will provide 
further information on the changes in expression and cellular localization observed.   
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Figure 5.3. Comparing cellular localization and expression levels of wild type HA and wild type co-
transfected with mutant HA. A) Wild type HA appears to localize along the plasma membrane. B – F) 
Analyzing expression of wild type HA co-expressed with mutant HA, A11E – B, V13L – C, A17E – D, 
D18N – E and T19P – F. 
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Materials and methods 
Cell culture  
MDCK cells were maintained in cell culture media consisting of Eagle’s Minimal Essential 
Media supplemented with 10% fetal bovine serum, 100U/mL penicillin and 100µg/mL 
streptomycin grown at 37°C and 5% carbon dioxide. 293T cells were maintained in Opti-MEM I 
media supplemented with 5% fetal bovine serum, 100U/mL penicillin and 100µg/mL 
streptomycin grown at 37°C and 5% carbon dioxide. 
 
Virus recovery  
Mutations of interest were identified from a previous high-throughput mutational scan (in 
publication) that used next-gen deep sequencing to measures effects of all possible single 
nucleotide mutations in the HA signal sequence. A panel of 19 variants was generated using the 
pHW2000-based 8-plasmid system developed by Webster and colleagues [15]. Briefly, 1 µg of 
wild type HA plasmid library and 1 µg of each plasmid encoding the rest of the A/WSN/33 
genome, were transfected in a co-culture of MDCK and 293T cells using TransIT LT1 reagent. 
For the mutants of interest 0.5 µg of wild type HA was mixed with 0.5 µg of mutant HA and 
transfected with plasmids encoding the rest of the genome. Media was changed to serum-free 
media 6 h post-transfection. At 30 h post-transfection, TPCK trypsin was added to a final 
concentration of 0.5 µg/mL. Virus-containing supernatant was harvested at 72 h post-
transfection, centrifuged at 300g for 15 minutes and stored at -80°C.  
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Titer reduction assay 
Viral titer of recovered viruses was quantified by plaque assay as previously described [100]. 
Briefly, 5x105 MDCK cells per well were seeded 24 h before infection. Harvested virus was 
diluted in a 10-fold serial dilution in wash buffer and added to cells. Cells were incubated with 
virus for 1 h. Virus was removed from cells and replaced with agar overlay. Infected cells were 
incubated for 48 h at 37°C and 10% CO2. Immunostaining of plaques was performed with anti-
NP antibody, and plaques were visually counted and plaque size measured using a Nikon 
SMZ1500 microscope. 
 
HA expression in mammalian cells 
HA variants were cloned into the JB991 plasmid, kindly provided by J. Bloom (University of 
Washington, Seattle), that has a CMV promoter, a GFP reporter, and an ampicillin selection 
marker. HA clones were transiently expressed in 293T. Cells were harvested 24 h post-
transfection, washed and resuspended in isotonic buffer (15 mM MOPS, 145 mM NaCl, 2.7 mM 
KCl, 4 mM CaCl2 pH 7.4. 2% heat-inactivated FBS). Cells were stained with rabbit HA antibody 
for 1 h at room temperature followed by Alexa Fluor 647 goat anti-rabbit IgG secondary 
antibody. Stained cells were washed, resuspended in isotonic buffer and analyzed on a BD 
FACSCalibur. Data analysis was conducted using the FlowJo data analysis software package. 
 
Studying cellular localization using immunofluorescence microscopy 
HA variants were cloned into the JB991 plasmid and transiently expressed in 293T. At 24 h post-
transfection, cells were fixed using 4% paraformaldehyde in PBS and stained with influenza A 
virus H1N1 HA primary antibody, followed by Alexa Fluor 647 secondary antibody, anti-
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calreticulin antibody and Alexa Fluor 549 secondary antibody. Images were acquired using a 
Nikon Eclipse Ni-U microscope at 40x magnification using NIS-Elements imaging software 
(version 4.13). 
 
Western blot analysis 
HA variants were transiently expressed in 293T cells. Cells were washed and lysis buffer 
supplemented with PMSF was added to cells and incubated for 15 mins at 25°C. Cells were then 
scraped from wells and centrifuged at 1200 rpm for 2 mins. Cell lysates were collected and 
stored at -80°C. 20µg of total protein was loaded per well and blotted using HA antibody, 
calreticulin antibody and alpha-actin antibody.  
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